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93. ABSTRACT
The repair of corneal wounds requires both epithelial cell adhesion and migration. 
Basement membrane (BM) and extracellular matrix (ECM) proteins function in these 
processes via integrin and non-integrin receptors. We have studied the adhesion, spreading 
and migration of immortalized human corneal epithelial (HCE) cells and their interactions 
with the laminins, fibronectins and tenascins produced.
Among laminin (Lm) chains, the ?3 and ?5 chains were detected in the BM of the human 
cornea, while Lm ?1 was not found in these experiments. This result showed that human 
corneal BM expresses Lms-332 and -511. HCE cells produced Lm ?3’, ?3, ?3, ?2’ and ?2
chains to the culture medium, whereas neither Lm-111 nor Lm-511 was produced. Both 
Lm ?2’ and ?2 chains were also found in a cell-free ECM preparation of HCE cells. 
Because HCE cells did not produce Lm-511, although it was present in corneal BM, we 
suggest that Lm-511 is produced by stromal keratocytes. 
The adhesion of HCE cells to Lms-111, -332 and -511 was studied first by determining the 
integrin and non-integrin receptor composition of HCE cells and then by using 
quantitative cell adhesion assays with function-blocking monoclonal antibodies (MAbs). 
Immunofluorescence studies revealed the presence of integrin ?2, ?3, ?6, ?1 and ?4
subunits. The cells adhered via integrin ?3?1 to both purified human Lms-332 and -511 as 
well as to endogenous Lm-332. Although several available function-blocking MAbs to 
integrin ?-subunits were tested, we could only demonstrate the role of integrin ?1 subunit
in HCE cell adhesion to mouse Lm-111. Among the non-integrin receptors, Lutheran (Lu) 
was found by Northern blot analysis as 4.0 and 2.8 kb mRNA transcripts. This receptor 
was located to the basal aspect of basal corneal epithelial cells in vivo and as punctate 
reactivity on the cell surfaces of adhering HCE cells. On the other hand, ?- and ?-
dystroglycans were not present in cornea or HCE cells. The adhesion of HCE cells to Lm-
511 was mediated by Lu as well as by integrin ?3?1. Since the adhesion of HCE cells to 
Lm-511 did not induce Lu into focal adhesions (FAs), we suggest that Lm-511 serves as 
an ECM ligand enabling cell motility.
HCE cells produced and deposited extradomain-A fibronectin (EDA-Fn), oncofetal 
fibronectin (Onc-Fn) and tenascin-C (Tn-C), which are also found during corneal wound 
healing. Furthermore, the results showed that Tn-C is deposited vectorially since it was 
only found in ECM. EDA-Fn and Onc-Fn by contrast, were present both in ECM and in 
culture medium of HCE cells. Integrin ?5?1, which was found in FAs and cell surface-
associated ECM adhesions in HCE cells, mediated the adhesion of HCE cells to Fn. 
However, during the adhesion, integrin ?5?1 functioned in concert with integrin ?v?6 and
both were localized in FAs. Arginine-glycine-aspartic acid (RGD) peptide inhibited the 
adhesion of HCE cells to fibronectin as well as to vitronectin. Integrin ?v?6 appeared to be 
the receptor mediating HCE cell adhesion to vitronectin. Although the cells did not adhere 
to Tn-C, they adhered to the Fn/Tn-C coat and were then more efficiently inhibited by the 
function-blocking MAbs against integrin ?5 and ?1 subunits as well as RGD peptide.
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During the early adhesion, HCE cells codeposited Lm-332 and the large subunit of 
tenascin-C (Tn-CL) as a restricted plaque beneath the cells via the Golgi apparatus and 
microtubules. Integrin ?4 subunit, which is a hemidesmosomal component, did not 
mediate the early adhesion of HCE cells to Lm-332 or Lm-332/Tn-C. Based on these 
results, we suggest that the adhesion of HCE cells is initiated by Lm-332 and modulated 
by Tn-CL, as it has been reported to prevent the assembly of hemidesmosomes. Thereby, 
Tn-CL functions in the motility of HCE cells during wound healing. The different 
distribution of Lm-332 and Lm-?3’32 in adhering, spreading and migrating HCE cells 
suggests a distinct role for these isoforms. We conclude that the processed Lm-332 
functions in cell adhesion, whereas the unprocessed Lm-3’32 participates in cell spreading 
and appears to be produced by HCE cells starting to migrate in experimental wounds. 
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4. INTRODUCTION
The cornea functions as an optical lens that transmits and focuses light to the retina. This 
role requires that it is transparent and sufficiently curved. Thus, the cornea has a unique 
structure exhibiting several special characteristics, such as the specific composition and 
organization of stromal collagen fibrils (Meek and Boote, 2004), avascularity and rigidity. 
Refractive surgery has been one of the major topics in the field of ophthalmology during 
recent years. Understanding of the restoration of corneal structure after corneal wounding 
is important in the development of new treatments for corneal epithelial defects and to 
obtain best surgical outcomes.
Corneal wound healing follows a similar pattern to wound healing of the skin and other 
stratified squamous epithelia of body tissues, although variations exist in the extent of 
these processes. Characteristic features of corneal wound healing are the complex cellular 
interactions between epithelial cells and stromal keratocytes mediated by cytokines and 
growth factors and leading to a non-fibrotic healing process (Fini and Srramer, 2005; 
Wilson et al., 1999). These stromal-epithelial interactions mediate such processes as 
corneal epithelial cell migration, proliferation and differentiation, all of which are required 
for proper re-epithelization of a defective cornea (Suzuki et al., 2003). Prior to cell 
migration, ECM proteins, such as fibronectin and tenascin-C, are secreted to the wound 
surface (Tanaka et al., 1999; Tervo et al., 1991a). Specific cell membrane structures, 
including e.g. filopodia, lamellipodia and focal contacts, which connect the ECM proteins 
via cell surface receptors to intracellular cytoskeletal fibres, participate in cell migration 
(Small and Resch, 2005; Small et al., 1996). Normally after photorefractive keratectomy, 
the wound area is covered by an adjacent intact epithelial cell monolayer and is followed 
by cell proliferation and restoration of normal epithelial thickness in two to three days 
(Fagerholm, 2000). This early phase in wound healing serves not only to recover vision 
but is also important as a barrier against infections. The restoration of corneal epithelium, 
is not however completed for some weeks, until the permanent anchoring structures 
consisting of hemidesmosomes, desmosomes and tight as well as adherens junctions are 
established (Suzuki et al., 2003). Stromal regeneration, which involves a variety of cells, 
continues for months. While some of the stromal keratocytes undergo early-phase 
apoptosis (Laube et al., 2004; Li et al., 2000; Netto et al., 2005; Wilson, 2000), others 
proliferate, migrate or transform into myofibroblasts (Kuo, 2004). Stromal remodelling 
includes production and reabsorption of collagen and production of glycosaminoglycans 
by fibroblasts and myofibroblasts (Kuo, 2004). Inflamatory cells, including 
polymorphonuclear leukocytes and monocytes/macrophages, invade the wound area via 
limbal vessels and tear fluid (Fagerholm, 2000; Mohan et al., 2003a; Wilson et al., 2004). 
These cells are responsible for cleaning the wound of cell debris and bacteria. The wound 
contraction is accomplished by myofibroblasts (Jester et al., 1995).
BM demarcates corneal epithelial cells from Bowman`s layer as a thin layer of ECM. 
Laminins are heterotrimeric glycoprotein components of BMs that participate in several 
essential processes, such as cell adhesion, proliferation, migration and differentiation 
(Colognato and Yurchenco, 2000). Laminins function in these cellular activities by 
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utilizing transmembrane cell surface receptors. Integrins, which mediate bidirectional 
signalling between the ECM and the intracellular cytoskeleton, are the best-characterized 
receptors of laminins and other ECM proteins (Hynes, 2004). Fibronectin is expressed 
widely in the cornea (Tuori et al., 1996) and is able to promote cell adhesion (Ruoslahti, 
1988), whereas tenascin-C (Tn-C) is restricted to the limbal area (Maseruka et al., 2000) 
and has been considered to modulate cell adhesion (Murphy-Ullrich, 2001; Orend and 
Chiquet-Ehrismann, 2000).
To investigate the dynamics of corneal epithelial cells during adhesion and wound healing, 
cultured cells are an obvious choice. There are several methods to culture and propagate 
primary HCE cells isolated from tissues. However, the problem is that usually the cells 
can be propagated only for a few generations and pieces of corneas available for culture 
are scarce. Immortalized corneal epithelial cells have been established with an extended 
culture life. In these studies, immortalization either by Simian virus 40 (SV40) (Araki-
Sasaki et al., 1995; Kahn et al., 1993; Offord et al., 1999) or human papilloma virus 
(HPV)-16 genome (Mohan et al., 2003b) have been used. Among these models SV40 
transformed HCE cells have been most widely used. Primary cultures of HCE cells were 
for this purpose infected by Dr. Araki-Sasaki and colleagues (1995) with a recombinant 
SV40 adenovirus vector and were cloned three times to obtain a continuously growing cell 
line that does not shed free viruses. HCE cells succeeded in growing for more than 400 
generations and exhibited a typical cobblestone-like appearance, resembling that of 
primary corneal epithelial cells in culture. Both the original study and studies thereafter 
(Huhtala et al., 2003) have shown that these cells express cornea-specific keratins together 
with some simple epithelial cell cytokeratins not found in the cornea in vivo. Moreover, 
HCE cells were shown to differentiate in a multilayered fashion at the air-liquid interface. 
Further studies have revealed HCE cells to be a promising corneal substitute for drug 
delivery research (Toropainen et al., 2003; Reichl et al., 2004). 
In this work, the distribution of laminin isoforms in human corneal BM and their synthesis 
by HCE cells was studied. Furthermore, the production and deposition of fibronectin and 
Tn-C by HCE cells was investigated. To obtain more information on the adhesion 
characteristics of HCE cells to these BM and ECM proteins, the integrin and non-integrin 
receptors of HCE cells were also studied. Corneal wound healing involves epithelial cell 
adhesion, spreading and migration, all of which were considered in this thesis.
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5. REVIEW OF THE LITERATURE 
5.1 Extracellular matrix 
Tissues are composed of cells and surrounding networks of macromolecules forming the 
ECM. The amount and the organization of these macromolecules vary, reflecting the 
function of each tissue. The epithelial tissues rest on a thin sheet of specialized ECM, 
called the BM. In the connective tissue, the cells are embedded among ECM molecules 
and ground substance. The major elements of ECM are fibrillary proteins, collagens and 
elastins, non-fibrillary proteins, such as fibronectins and tenascins, and BM molecules, 
including laminins, collagen IV and nidogen. The ground substance consists of 
glycosaminoglycans, proteoglycans and proteoglycan aggregates. ECM molecules interact 
with cells via cell surface receptors, affecting cell survival, differentation, migration, 
proliferation and shape (Adams and Watt, 1993; Hagios et al., 1998). Additionally, ECM 
resists compressive forces, permits diffusion of nutrients, metabolites and hormones and 
serves as a reservoir for growth factors and cytokines. As ECM is a dynamic structure, 
there is a regulated continuous remodelling of these macromolecules.
5.2 Basement membrane – a dynamic structure with diverse functions 
BMs consist of specialized ECM molecules that as a thin sheet-like structure underlie 
epithelial and endothelial cells, separating them from connective tissue. In addition, BMs 
encircle individual fat cells, muscle cells and Schwann cells. Although the existence of 
BM has been proposed since the nineteenth century, only more recently have 
histochemical, immunohistochemical, biochemical and molecular biological techniques 
yielded  information about its structure and function. Ultrastructural studies have shown 
three BM zones: lamina lucida, lamina densa and lamina fibroreticularis (for review, see 
Merker, 1994; specifically for cornea, see Beuerman and Pedroza, 1996). Our knowledge 
of the molecular structure of the BM is based first of all on the studies of Nikolas 
Kefalides and his collaborators (1979), who showed that type IV collagen is a major BM 
protein. This protein exists in several isoforms and assembles into multilayered networks 
located throughout the BM (Yurchenco and Ruben, 1988). A major breakthrough in BM 
research was when laminin was isolated from a mouse Engelbreth-Holm-Swarm (EHS) 
tumour and shown to be a BM component (Timpl et al., 1979). Timpl and Brown (1996) 
later established that type IV collagen and laminin networks were connected to each other 
by nidogen/entactin. Proteoglycans, agrin, perlecan and type XVIII collagen are also 
ubiquitous structural components of BMs, playing distinct roles in many cellular functions 
(Iozzo, 2005).
The complex structure of BMs not only provides mechanical stability for cells, but also 
enables BMs to act in a variety of biological processes. Since the 1980s, this dynamic 
structure has been shown to be involved in numerous processes in developing embryo and 
adult tissues (Miner and Yurchenco, 2004; Yurchenco et al., 2004).
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5.3 Laminin isoforms – a growing glycoprotein family controlling tissue 
organization and cellular functions
An antiserum raised against the first laminin reacted with most of the body BMs (Rohde et 
al., 1979; Timpl et al., 1979). It gradually became clear that laminin is not only one 
protein; to date 15 different laminin isoforms have been described (Aumailley et al., 
2005).
Laminins, which are multidomain trimeric proteins found in all BMs, consist of one ?-,
one ?- and one ?-chain. At present, 5 ?-chains, 3 ?-chains and 3 ?-chains have been 
characterized. These chains associate via triple α-helical coiled-coil domains with 
disulphide bonds and have molecular masses between 140 and 400 kD. Laminins 
assemble into large crucifix- or T-shaped proteins comprising one long arm and two or 
three short arms (Aumailley et al., 2005; Miner and Yurchenco, 2004; Patarroyo et al., 
2002). Laminin chains to some extent resemble each other and typically consist of 
domains. The domains are named from the laminin aminoterminus of the Lm-111 
molecule as follows: laminin N-terminal globular (LN) domain, laminin epidermal growth 
factor-like (LE) domain, L4 domain, laminin four (LF) domain, coiled-coil domain, ?-
knob domain and LG tandem (Aumailley et al., 2005). All these domains are not present 
in the three laminin chains. Five globular LG modules are arranged in tandem within the 
C-terminus of all known laminin ? chains (Sasaki et al., 1988). These LG modules have 
been shown to interact with cellular receptors such as integrins, dystroglycans and 
Lutheran blood group glycoprotein (Lu) (Miner and Yurchenco, 2004).
Because of the increase in the number of members of the laminin family, a nomenclature 
was presented in 1994 to replace the earlier diverse names. In this system, laminins were 
numbered with arabic numerals according to the order of discovery. The genes for laminin 
chains were named LAMA, -B and -C for ?-, ?- and ?-chains, respectively (Burgeson et 
al., 1994). A new simple laminin nomenclature has now been introduced to reveal the 
chain composition of each laminin (Aumailley et al., 2005). This laminin nomenclature 
and chain composition are presented in Table 1 and are used in this review. 
The structural diversity of laminins enables highly specialized functions. Laminins 
provide a substratum for cell adhesion and migration and play a role in cell proliferation, 
differentiation, filtration and cell survival (Chen and Strickland, 2003; Colognato and 
Yurchenco, 2000; DeHahn et al., 2004; Ekblom et al., 1980; Frank and Carter, 2004; 
Nguyen et al., 2000). The expression of laminins is regulated spatially and temporally in a 
tissue-specific manner (Fleischmajer et al., 2000; Sanes et al., 1990; Virtanen et al., 1995; 
1996). In recent years, mutations in laminin genes have been found to cause several 
organelle dysfunctions. In addition, the generation of knock-out mice for laminin chains 
has provided new information about their specific functions and new models for human 
diseases (Miner and Yurchenco, 2004).
Both laminin ?1 chain- and ?1 chain-deficient mouse embryos die during the early 
postimplantation period after embryonic day 6.5 or 5.5 due to failure of endoderm 
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differentiation and BM formation, respectively (Alpy et al., 2005; Miner et al., 2004; 
Smyth et al., 1999). Also homozygous Lm ?5 -/- mice suffer from multiple defects in 
tissue morphogenesis and differentiation and do not survive past embryonic day 15 to 17 
(Miner et al., 1998). On the other hand, ?2 chain deficiency does not play an important 
role during early embryonic development, but such mice have defects in renal glomerular 
filtration and neuromuscular junctions as well as ocular abnormalities, including 
microcoria, and the mice die postnatally (Miner et al., 2006; Noakes et al., 1995a; b). 
Particularly muscular defects in Lm ?2 chain mutant mice correlate with the severe 
failure-to-thrive phenotype (Miner et al., 2006). In nephrotic mutant mice, Lm ?2 chain 
was structurally replaced by ?1 chain, but the glomeruli did not function properly, 
reflecting the highly chain-specific functions of laminins (Noakes et al., 1995a). In man, 
mutations in LAMB2 gene may cause congenital nephrotic syndrome with microcoria 
(Pierson´s syndrome; see Zenker et al., 2004; 2005; VanDeVoorde et al., 2006), or 
nephrotic syndrome with or without minor ocular changes (Hasselbacher et al., 2006). 
Thyboll et al. (2002) discovered that laminin ?4-null mice show extensive bleeding and 
deterioration of microvessel growth, demonstrating a central role for this laminin chain in 
microvessel organization. Some muscular dystrophies have been found to be associated 
with laminin chain deficiencies such as merosin-deficient (Lm ?2-deficient) congenital 
muscular dystrophy (Helbling-Leclerc et al., 1995; Hillaire et al., 1994; Tome et al., 
1994). Indirect immunofluorescence studies have shown that the expression of Lm-332 is 
defective in the epithelial BMs of patients with junctional epidermolysis bullosa of 
Herlitz`s type (Meneguzzi et al., 1992). Furthermore, several studies have revealed that 
mutations in genes encoding laminin ?3, ?3 and ?2 chains are involved in the pathogenesis 
of the aforementioned disorder, resulting in blistering (Kivirikko et al., 1995; 1996; 
Pulkkinen and Uitto, 1999). Lm-332 together with Lm-511 will be discussed in more 
detail in Sections 5.3.1 and 5.3.2.
Table 1. New laminin nomenclature 
Chain composition Current name Previous name 
?1?1?1 Laminin-111 Laminin-1, EHS-laminin 
?2?1?1 Laminin-211 Laminin-2, merosin 
?1?2?1 Laminin-121 Laminin-3, s-laminin 
?2?2?1 Laminin-221 Laminin-4, s-merosin 
?3?3?2 Laminin-332 Laminin-5, kalinin/nicein/epiligrin 
?3?1?1 Laminin-311 Laminin-6, k-laminin 
?3?2?1 Laminin-321 Laminin-7, ks-laminin 
?4?1?1 Laminin-411 Laminin-8 
?4?2?1 Laminin-421 Laminin-9 
?5?1?1 Laminin-511 Laminin-10 
?5?2?1 Laminin-521 Laminin-11 
?2?1?3 Laminin-213 Laminin-12 
?3?2?2 Laminin-322 Laminin-13   
?4?2?3 Laminin-423 Laminin-14 
?5?2?3 Laminin-523 Laminin-15 
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5.3.1 Laminin-332
Lm-332 was described independently by several research groups as BM 600 (Verrando et 
al., 1987), kalinin (Rousselle et al., 1991), epiligrin (Carter et al., 1991), nicein 
(Marinkovich et al., 1993) and ladsin (Miyazaki et al., 1993). Numerous studies have 
thereafter demonstrated that this protein participates in different processes, including 
epithelial cell adhesion, spreading and migration (Hintermann and Quaranta, 2004;
Nguyen et al., 2000). The deposition of precursor Lm-332, which interacts with integrin 
?3?1, has been shown to promote polarization and migration of human primary 
keratinocytes in cell culture (Frank and Carter, 2004) as well as in epidermal wounds
(Nguyen et al., 2000). On the other hand, Lm ?3 chain was also shown to function in the 
induction and maintenance of cell adhesion and to mediate hemidesmosome formation 
(Baker et al., 1996). These opposite roles of Lm-332 have been explained by the 
processing of LG domains of ?3 chain, with only the processed ?3 chain appearing to 
induce hemidesmosome formation and cell adhesion via integrin ?6?4 (e.g. Hintermann 
and Quaranta, 2004).
The Lm ?3 chain exists in two chain variants, ?3A and ?3B, due to alternative splicing 
(Airenne et al., 2000; Aumailley et al., 2003). Therefore, Lm-332 is a T-shaped or 
cruciform molecule with truncations in all three short arms. The N-terminal region of the 
short splice variant ?3A contains only laminin-type epidermal growth factor-like domains 
LEc1-3, the ?3 chain has six LE domains and one globular LN domain, and the ?2 chain 
has six LE domains and one globular L4m domain (Aumailley et al., 2003). By contrast, 
the full-length N-terminal region of the ?3B chain consists of additional LN, LEa, LEb, 
L4a and L4b domains (Aumailley et al., 2003). The C-terminal region of the unprocessed 
200 kD ?3 chain folds into five LG domains and is proteolytically cleaved into a 165 kD 
chain after secretion (Marinkovich et al., 1992). The precursor 155 kD ?2 chain is also 
subjected to processing of its N-terminal domains, resulting in a 105 kD chain 
(Marinkovich et al., 1992; Rousselle et al., 1991). The 140 kD ?3 chain remains 
unprocessed.
Based on mRNA expression studies, Kallunki et al. (1992) found ?2 transcript in human 
fetal skin, lung, kidney, thymus and cerebellum. Galliano et al. (1995), by contrast, 
described a very tissue-specific expression of laminin ?3A and ?3B mRNAs in only 
epithelial tissues, such as skin, tooth germ, respiratory tract, alimentary tract, kidney 
collecting tubules and also focally in the central nervous system. In another study, Lm ?3
mRNA was reported to be strongly expressed during wound repair (Ryan et al., 1994).  
Kawano et al. (1999) thoroughly studied the localization of Lm-332 in human tissues by 
immunohistochemistry. Their results showed that Lm-332 is located in the BMs of nearly 
all epithelial tissues. However, only a cytoplasmic fluorescence for Lm-332 was found in 
the fundic glands of the stomach and hepatocytes, and it was lacking in the BMs of these 
structures. The BMs as well as the cytoplasm were negative for Lm-332 in the acini of the 
pancreas, submaxillary glands and bronchial submucosal glands. 
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5.3.2 Laminin-511
The first laminin was isolated from a mouse Engelbreth-Holm-Swarm (EHS) tumour 
(Timpl et al., 1979), and it was called EHS-laminin or laminin-1, and is now known as 
Lm-111. Several studies with MAb 4C7, which was originally raised against human 
placental laminin and considered to recognize in human tissues ?1 chain of Lm-111 
(Engvall et al., 1986), suggested a widespread BM distribution for it in human tissues 
(Engvall et al., 1990; Sanes et al., 1990; Virtanen et al., 1995). However, further studies 
with many human tissues, such as kidney, lung and muscle, revealed a restricted mRNA 
expression for the laminin ?1 chain (Vuolteenaho et al., 1994). Additionally, when Miner 
et al. (1995) cloned and described mouse Lm ?5 chain and proposed that it may be a major 
laminin chain of most adult mouse BMs, suspicions considering the specificity of MAb 
4C7 were aroused. The suggestion that MAb 4C7 might cross-react with Lm ?5 chain was 
substantiated in a later study (Miner et al., 1997) in which the authors compared the 
distribution of all known laminin ?-chains (1-5) in mouse tissues. They concluded that in 
adult mouse tissues Lm ?5 chain is the most widely distributed ? chain, while Lm ?1
chain was found in a much more restricted distribution. They also resolved the ambiguity 
considering MAb 4C7 and concluded that it recognizes Lm ?5 chain in addition to or 
instead of ?1 chain. Finally, during the same year, Tiger et al. (1997) conclusively showed 
that MAb 4C7 reacts solely with human Lm ?5 chain. These findings bear substantial 
importance; numerous studies conducted with MAb 4C7 had to be re-interpreted and a 
very wide distribution was suggested for Lm ?5 chain in nearly all human adult BMs, with 
a few exceptions, such as skeletal muscle cells. All epithelial BMs appear to contain Lm 
?5 chain. 
Lm ?5 chain is required during embryogenesis and studies with knock-out mice have 
revealed severe defects, such as exencephaly, syndactyly and placentopathy, leading to 
lethality late in embryogenesis (Miner et al., 1998). Further studies with ?5 -/- mutant 
mouse embryos and using inducible expression of ?5 chain in laminin ?5-null mice have 
shown that it is crucial for hair morphogenesis (Li et al., 2003), distal lung epithelial 
maturation, VEGF production and lung alveolization (Nguyen et al., 2005), intestinal 
smooth muscle development (Bolcato-Bellemin et al., 2003) and kidney mesangial cell 
organization (Kikkawa et al., 2003). Furthermore, Lm-511 has a significant role in cell 
adhesion, proliferation and migration (Kikkawa et al., 1998; Pouliot et al., 2002; Tani et 
al., 1999). Lm ?5 chain as a component of Lm-521, on the other hand, shows a restricted 
distribution to synaptic BM and BMs of kidney glomeruli and arterial smooth muscle 
(Miner and Patton, 1999). Diabetic corneas show a reduced amount of Lm ?5 chain in 
BMs and overexpression of matrix metalloproteinase (MMP)-10, which has been found to 
degrade several laminin chains (Ljubimov et al., 1998; Saghizadeh et al., 2001). 
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5.4 Fibronectin
Fibronectin is an ECM glycoprotein that exists in body fluids as a soluble plasma 
fibronectin and is produced by hepatocytes (Tamkun and Hynes, 1983). It is also found 
throughout the ECM of connective tissues as an insoluble protein (Stenman and Vaheri, 
1978). Fibronectin is a dimer composed of two 250 kD subunits, which are covalently 
linked near the C-termini by disulphide bonds. Three types of repeating units, each 
composed of a series of independently folding modular domains, form the fibronectin 
monomers: type I, type II and type III repeats (Pankov and Yamada, 2002). Fibronectin is 
encoded by a single gene and exists in multiple forms resulting from the alternative 
splicing of the primary transcript (ffrench-Constant, 1995; Tamkun et al., 1984). The 
alternative splicing occurs at three sites: EIIIA (EDA), EIIIB (EDB) and the V (variable in 
length) region (Kornblihtt et al., 1996; Schwarzbauer, 1991).
In addition to EDA-Fn and EDB-Fn, a third isoform called Onc-Fn exists. This isoform, 
which is differentially glycosylated (Matsuura et al., 1988; Matsuura and Hakomori, 
1985), shows a restricted expression solely in fetal and tumour tissues (Matsuura and 
Hakamori, 1988). All of the alternatively spliced fibronectin isoforms have a temporally 
and spatially regulated expression in chicken embryos (ffrench-Constant and Hynes, 
1989). In embryonic human tissues, the EDA-Fn isoform is abundant in many BMs, while 
in adult tissues it is mostly confined to endothelia of larger blood vessels and to smooth 
muscle cells (Vartio et al., 1987). EDB-Fn has even more restrictive distribution, e.g. in 
the human kidney (Laitinen et al., 1991), being found in only some BMs of fetal tissues 
and more generally in developing vessels, and has been suggested to serve as a marker for 
angiogenesis (Castellani et al., 1994).
The multifunctional fibronectin has been suggested to play a role in cell adhesion and 
migration during development and wound healing, as well as in many cellular processes 
such as proliferation, survival, differentiation and blood clotting (ffrench-Constant et al., 
1989; Hynes, 1986; Schwarzbauer, 1991). Gene knock-out studies have revealed that the 
expression of fibronectin is essential for embryogenesis, as gene inactivation causes early 
embryonic lethality (George et al., 1993). The embryos showed a wide variety of 
abnormalities. However, much less is known about the specific functions of fibronectin 
isoforms. Gene knock-out studies have suggested that EDA-Fn is necessary in, for 
instance,  proper epidermal wound healing and normal life span (Muro et al., 2003) as well 
as in proper motor coordination (Chauhan et al., 2005). In addition, the differentiation of 
fibroblasts to myofibroblasts, which are required in wound contraction, is regulated by 
EDA-Fn (Desmouliere et al., 2005). Mice lacking EDB-Fn developed normally, but 
showed reduced cell growth and impaired fibronectin matrix assembly (Fukuda et al., 
2002).
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5.5 Tenascin-C
Tenascins (Tns) are a highly conserved family of oligomeric glycoproteins (Jones and 
Jones, 2000; Hsia and Schwarzbauer, 2005). Tn-C, the first described protein among the 
five members of the tenascin family (-C, -R, -X, –W and -Y), was discovered in several 
laboratories in the early 1980s. Tn-C belongs to matricellular proteins, which have a 
modulatory role in cell adhesion (Orend and Chiquet-Ehrismann, 2000; Hsia and 
Schwarzbauer, 2005; Murphy-Ullrich, 2001). Although Tn-C is highly expressed during 
development of many tissues, it is only sparsely expressed in adult tissues. However, it 
becomes re-expressed upon wound healing, inflammation and tumorigenesis (Jones and 
Jones, 2000). 
Tn-C was first considered to be synthesized by mesenchymal cells (Erickson and Bourdon 
1989), but is now known to also be produced by epithelial cells (Linnala et al., 1993; 
Latijnhouwers et al., 1997; Lightner et al., 1994). It was originally described as a six-
armed huge macromolecule called a hexabrachion (Erickson and Iglesias, 1984; Jones et 
al., 1989), assembling in the cells rapidly after translation (Redick and Schwarzbauer, 
1995).
The subunits of mammalian Tn-C consist of a amino-terminal oligomerization region, 
heptad repeats, EGF-like repeats, fibronectin type III repeats and a carboxyl-terminal 
fibrinogen-like globular domain (Hsia and Schwarzbauer, 2005). Alternative splicing, 
resulting in the inclusion or exclusion of fibronectin type III repeats, ensures the formation 
of isoforms (Jones and Jones, 2000; Chiquet-Ehrismann and Chiquet, 2003).
Attempts to elucidate the fundamental functions of Tn-C have been made with knock-out 
mice studies. A surprising first finding was that Tn-C -/- mice appeared to develop 
normally (Saga et al., 1992). Further studies with these mice indicated that epidermal 
wounds and severed nerves also healed in these mice normally (Forsberg et al., 1996). 
However, abnormal re-innervation of skeletal muscle (Cifuentes-Diaz et al., 2002), normal 
myelinization but abnormal behaviour (Kiernan et al., 1999) and suppression of 
hematopoietic activity (Ohta et al., 1998) have been found in these mice. Most of the 
findings have indicated rather subtle morphological and/or physiological changes that 
may, however, play an essential role in the survival of an animal (Hsia and Schwartzbauer, 
2005).
5.6 Integrins and non-integrin basement membrane and extracellular matrix 
receptors
During the 1980s many attempts were made to define integral cell surface glycoproteins of 
nucleated cells that could be considered receptors for ECM proteins, especially for 
fibronectin. Ruoslahti and his collaborators (Pytela et al., 1985a) first described a 140 kD 
cell surface glycoprotein that showed properties of a fibronectin receptor, later called 
integrin ?5?1. Integrins today form a large family of related proteins. Currently, 18 ?- and 
8 ?-subunits have been characterized in mammals, forming at least 24 integrin dimers. 
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These covalently associated subunits bind various ligands such as cell surface proteins, 
collagens, fibronectins, laminins, Tn-C and vitronectin (Danen, 2005; Hynes, 2004).
Heterodimeric integrins recognize partially cell-type specifically distinct ECM and BM 
components. The same integrin receptor in distinct cell lines may recognize different ECM 
proteins (Languino et al., 1989). Ligand binding leads to conformational changes in 
integrins and activates cytoplasmic signalling pathways (Mould and Humphries, 2004). 
This signal transduction induces numerous cellular processes, including microfilament 
dynamics and organization, adhesion complex remodelling, migration, gene expression 
and cell cycle regulation (Danen, 2005; Hynes, 2002; Martin et al., 2002).
Fibronectin contains specific integrin binding sequences (Plow et al., 2000), one of them 
being the arginine-glycine-aspartic acid (RGD) tripeptide sequence. This sequence is 
recognized by integrin ?5?1 (Pierschbacher and Ruoslahti, 1984, Pytela et al., 1985a) and 
also by integrin ?v?3 (Pytela et al., 1985b). In addition, at least integrins ?4?1 and ?v?1
bind to fibronectin (Plow et al., 2000). The suggested integrin receptor binding sites for 
Tn-C are located in fibronectin type III repeats, fibrinogen-like globular domain or EGF-
like repeats (Hsia and Schwarzbauer, 2005;  Swindle et al., 2001). The RGD sequence, 
present in the third human and chicken fibronectin type III repeat of Tn-C, has been 
suggested to mediate adhesion  to integrins ?v?3 and ?v?6 (Prieto et al., 1993). Moreover, 
integrins ?2?1 (Sriramarao et al., 1993), ?8?3 (Schnapp et al., 1995) and ?9?1 (Yokosaki 
et al., 1994) have been reported to serve as receptors for Tn-C. Furthermore, integrin ?3?1
has been considered to be a promiscuous integrin receptor, recognizing different ECM and 
BM molecules such as laminins, collagens and fibronectins (Plow et al., 2000; Wayner et 
al., 1988). 
Some leucocyte integrins are involved in cell-cell interactions, but most of the integrins 
function in cell-ECM interactions, mediating bidirectional signals between cells and ECM. 
At least integrins ?2?1 (Pouliot et al., 2000), ?3?1 (Kikkawa et al., 1998; Tani et al., 
1999), ?6?1 (Kikkawa et al., 2000; Tani et al., 1999), ?6?4 (Kikkawa et al., 2000; 2004) 
and ?v?3 (Genersch et al., 2003; Sasaki and Timpl, 2001) have been demonstrated to be 
receptors for Lm-511, binding to its ?-chain at the C-terminal globular domain. Ido et al. 
(2004) showed that the binding site for integrins ?3?1 and ?6?1 is the LG3 module of Lm-
511. Integrins ?6?1, ?6?4 (Carter et al., 1991; Nishiuchi et al., 2003) and ?3?1 (Ebihara et 
al., 2000) also serve as receptors for Lm-332.
The non-integrin laminin receptors comprise Lutheran blood group antigen (Lu) (El 
Nemer et al., 1998; Udani et al., 1998; Zen et al., 1999) and the dystroglycan-glycoprotein 
complex (Henry and Campbell, 1999). Lu is a transmembrane glycoprotein belonging to 
the immunoglobulin superfamily. It was found to be overexpressed on the surface of sickle 
red blood cells (Udani et al., 1998), which tend to adhere to endothelial BMs by binding to 
the Lm ?5 chain (Lee et al., 1998). Kikkawa et al. (2003) have shown that the binding site 
for Lu is located in the Ln ?5 LG3 module and may also require Ln ?5 LG1-2 modules. 
Studies based on Northern blotting and immunostainings revealed that Lu is widely 
expressed in human tissues, such as fetal liver, placenta and arterial walls (Parsons et al., 
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1995), and in mouse tissues (Moulson et al., 2001). Dystroglycan was first discovered as a 
component of the dystrophin-glycoprotein complex in skeletal muscle and found to be 
associated with muscular dystrophies such as Duchenne muscular dystrophy (Ervasti et 
al., 1990; Henry and Campbell, 1999; Ibraghimov-Beskrovnaya et al., 1992). It is a 
glycoprotein composed of two non-covalently attached components: extracellular ?-
dystroglycan and transmembrane ?-dystroglycan. Dystroglycan provides a linkage 
between ECM and the cytoskeleton by binding to Lm ?1, ?2 (Ervasti and Campbell, 1993; 
Talts et al., 1999) and ?5 chains (Ido et al., 2004; Yu and Talts, 2003) as well as to a 
variety of intracellular molecules (Henry and Campbell, 1999).
Table 2. Integrins and their ligands (excluding leucocyte integrins) 
Integrin   Ligand 
?1?1    Lm-111, collagen 
?2?1    Lm-111, Tn-C, collagen 
?3?1    Lm-111, Lm-211, Lm-332, Lm-511 
?4?1    fibronectin 
?5?1    fibronectin 
?6?1    Lm-111, Lm-121, Lm-221, Lm-332, Lm-511 
?6?4    Lm-111, Lm-211, Lm-221, Lm-332, Lm-511 
?7?1    Lm-111 
?8?1    fibronectin, Tn-C 
?8?3    Tn-C 
?9?1    Lm-111, fibronectin, Tn-C   
?10?1    collagen 
?11?1    collagen 
?v?1    fibronectin 
?v?3    Lm-111, Lm-511, Fn, Tn-C, vitronectin 
?v?5    vitronectin 
?v?6    fibronectin, Tn-C 
?v?8    fibronectin, collagen 
5.7 Cell-matrix adhesions 
Adhesion of cells to external surfaces is a complex process, involving not only cell surface 
receptors and extracellular ligands, but also intracellular structures and signalling 
pathways (Blystone, 2004). Intracellular signalling activity affects gene expression, cell 
growth, differentiation, proliferation, migration and survival (Wu and Dedhar, 2001). 
Integrin-mediated cell-matrix adhesions are dynamic structures, having distinct molecular 
architectures and signalling properties (Berman et al., 2003; Sepulveda et al., 2005). 
Several factors affect these adhesion structures such as rigidity and molecular composition 
of the ECM (Ingber, 1997). Studies considering the initial state of cell adhesion reveal that 
a pericellular hyaluronan coat can mediate early adhesion prior to integrin engagement 
(Cohen et al., 2003; 2004). Integrin binding to ECM ligands and their clustering trigger 
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reorganization of actin cytoskeleton and intracellular proteins (Miyamoto et al., 1995; 
Schoenwaelder and Burridge, 1999), resulting in the formation of cell-matrix adhesions, 
including focal complexes, focal adhesions (FAs) and fibrillar adhesions. However, 
binding of integrins to ECM ligands is not sufficient to trigger focal adhesion assembly in 
many cell types, and additional activation of small GTP-binding protein Rho is required 
(Bershadsky et al., 2006; Hotchin and Hall, 1995). This activation leads to contraction of 
the actomyosin system through myosin light chain phosphorylation (Kureishi et al., 1997). 
Integrins commonly associated with cell-matrix adhesions are ?5?1, ?v?3 and ?v?5,
which bind to fibrinogen, fibronectin and vitronectin (Geiger et al., 2001). Focal 
complexes, small punctuating structures located on the edges of the lamellipodium in 
motile cells, have a unique protein composition (Zaidel-Bar et al., 2003). These structures 
are transient and may rapidly transform into bigger elongated FAs (Geiger et al., 2001), 
which are also known as focal contacts. FAs are protein complexes that consist of over 50 
known associated proteins, including vinculin, talin, paxillin and many phosphorylated 
proteins (Zamir and Geiger, 2001). Comparison of fibrillar adhesions with focal 
complexes and FAs reveals their more central orientation in the cell as well as the 
association of cytoplasmic tensin, integrin ?5?1 and fibronectin fibrils with these adhesion 
structures (Katz et al., 2000; Zamir et al., 1999; 2000).
5.8 Epithelial cell adhesion and migration – interplay between extracellular matrix 
and intracellular compartment 
Cell locomotion is essential in many physiological as well as pathological processes, 
including embryonic development, tissue maturation in renewable tissues, wound healing, 
inflammation and tumour cell invasion and metastasis. Cell migration involves repeated 
cycles of protrusion of lamellipodia, repeated adhesion to and detachment from ECM 
ligands (Friedl and Brocker, 2000; Small and Resch, 2005). The protrusions of the 
polarized cells used in migration are thin filopodia and broad lamellipodia, resulting from 
the actin polymerization into long parallel bundles or branching networks, respectively 
(Pollard and Borisy, 2003; Small and Resch, 2005; Welch and Mullins, 2000). The 
lamellipodia can grow into a particular direction, whereas the filopodia serve as sensors of 
the local environment (Ridley et al., 2003; Wood and Martin, 2002). Zaidel-Bar et al. 
(2003) showed that continuous assembly and disassembly of focal complexes, which can 
transform into focal adhesions, occurred in the advancing lamellipodium of endothelial 
cells during migration. The contractile actomyosin network has been suggested to induce 
forces that are involved in pulling of the cell body and trailing the cell edge forward 
(Lauffenburger and Horwitz, 1996). This process requires the disassembly of the 
adhesions of the rear edge (Ridley et al., 2003; Small and Resch, 2005). Integrins are 
major migration-mediating receptors, transmitting mechanical interactions as well as 
bidirectional signalling between cells and ECM or adjacent cells (Huttenlocher et al., 
1996).
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5.9 Cornea
5.9.1 Anatomy and histology of the cornea 
The cornea, which forms the anterior part of the eye, accounts for most of the eye`s 
refractive power. To maintain proper vision, the cornea must be avascular and transparent. 
It consists of five distinct layers, which can be distinguished by light microscope (Figure 
1). The outermost layer is the corneal epithelium, in the central cornea comprising five to 
seven layers of non-keratinized squamous epithelial cells. The number of cell layers 
increases towards the peripheral cornea, which is continuous with the conjunctival 
epithelium. The stem cells have been suggested to be located in the junction between these 
compartments, known as the corneoscleral limbus (Lavker et al., 2004). The limbal stem 
cell population is the ultimate source for corneal regeneration. Stem cell deficiency leads 
to abnormalities of the corneal structure, such as vascularization of the cornea, which 
eventually results in visual impairment or blindness (Dua et al., 2003). The low columnar 
basal epithelial cells are capable of limited divisions before terminal differentiation and 
migration towards the ocular surface and finally desquamation. The turnover time is 
approximately two weeks, reflecting a remarkable ability of the corneal epithelium to 
regenerate (Cenedella and Fleschner, 1990). To maintain the delicate corneal architecture, 
the corneal epithelial cells, like other stratified epithelial cells, must display distinct 
adhesive structures in the lateral and basal cell membranes (Ban et al., 2003; Jamora and 
Fuchs, 2002; Scott et al., 1997; Van Aken et al., 2000). Tight junctions, adherens junctions 
and desmosomes between corneal epithelial cells function as barriers and provide 
mechanical strength between adjacent cells (Ban et al., 2003; Petroll et al., 1999). 
Hemidesmosomes, on the other hand, reside on the basal aspect of basal corneal epithelial 
cells, attaching them to the underlying BM (Beuerman and Pedroza, 1996; Gipson, 1992) 
(Figure 2).
Bowman`s layer underlies the corneal BM and is the superficial part of the stroma. This 
acellular compartment is composed mainly of fibrils consisting of collagen types I, V, VI 
and XII (Birk, 2001; Ihanamäki et al., 2004). It has been suggested to represent stromal-
epithelial interactions and to lack a critical role in corneal physiology (Wilson and Hong, 
2000). The rest of the stroma consists of collagen fibrils, which form lamellae. These 
lamellae are oriented in precise angles with respect to adjacent lamellae, contributing to 
the transparency and strength of the cornea. Among collagens, at least types I, III, V, XII 
and XIII have been found in the corneal stroma (Birk, 2001; Ihanamäki et al., 2004). In 
addition, the stromal matrix contains several proteoglycans, which are responsible for 
proper spacing of collagen fibrils as well as for hydration of the stromal matrix (Ihanamäki 
et al., 2004). Keratocytes are arranged in networks between collagen lamellae, 
communicating with each other by gap junctions. These fibroblast-like cells produce a 
stromal matrix during the fetal period and in injuries and also maintain the normal corneal 
stromal matrix.
The BM of corneal endothelial cells is Descemet`s membrane, which is composed of 
collagen types IV, VI, VIII, laminins and fibronectins (Ihanamäki et al., 2004). This BM 
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material is produced by a monolayer of non-regenerating endothelial cells that function in 
fluid pumping and regulate corneal hydration. 
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Figure 1. Corneal structure.
A schematic representation of a section through the cornea shows five distinct layers. In addition, 
the corneal BM is illustrated in the figure. The corneal stroma does not contain blood or lymphatic 
vessels.
Figure 2. Structure of a hemidesmosome. 
This schematic diagram shows the components of the hemidesmosome, which provides an 
attachment between the basal corneal epithelial cell and the underlying ECM. 
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5.9.2 Basement membrane and extracellular matrix proteins and their receptors in 
the cornea 
Because corneal BM continues as limbal and conjunctival BM, it would be tempting to 
assume that the molecular composition of these compartments the same. However, studies 
on human and animal tissues have shown that the composition of corneal BM differs from 
that of limbal and conjunctival BM, indicating lateral heterogeneity (Lavker et al., 2004). 
Of the collagen protein family, which consists of more than 20 distinct collagens, at least 
collagen XVIII is found in the cornea. Type XVIII collagen was shown to be broadly 
expressed in mouse ocular tissues, including corneal epithelial BM (Kato et al., 2003). 
Early studies suggested that BM of the central cornea lacks collagen type IV (Cleutjens et 
al., 1990; Saika et al., 1995; Tuori et al., 1996). However, collagen type IV exists in six 
isoforms, and some of these isoforms are also found in corneal BM. Type IV collagen ?2
chains are only found in BMs of the conjunctiva and limbus (Fujikawa et al., 1984; 
Ljubimov et al., 1995; Saika et al., 1999; Tuori et al., 1996). This result was confirmed by 
Fukuda et al. (1999), who also showed that type IV collagen ?5 chains are only found in 
corneal BM, not in conjunctival BM or the amniotic membrane. However, the laminin 
composition of corneal and conjunctival BMs was identical. These results suggested that 
the molecular composition of amniotic membrane and conjunctival BM is the same. 
However, contrary to the conclusions of Fukuda et al. (1999), Endo et al. (2004) reported 
that type IV collagen ?5 chains are present in both amniotic membrane and corneal BM, 
implying that amniotic membrane may function as a substrate for corneal epithelial cells.
Adult human corneal BMs were first proposed to be composed of Lm-111 and Lm-332 
(Ljubimov et al., 1995; Tuori et al., 1996). The results leading to the assumption that Lm-
111 is a component of corneal BM were obtained with MAb 4C7, which is now known to 
recognize the Lm ?5 chain (Tiger et al., 1997). In vitro studies have demonstrated that 
during corneal wound healing Lm-332 participates in corneal epithelial cell adhesion and 
migration (Qin and Kurpakus, 1998; Ebihara et al., 2000). While the migration of corneal 
epithelial cells and keratinocytes has been reported to be mediated by precursor Lm-332 
interacting with integrin ?3?1 (Ebihara et al., 2000; Nguyen et al., 2000; Frank and Carter, 
2004), the processed Lm-332 appears to mediate epithelial cell adhesion via 
hemidesmosomes containing integrin ?6?4 (Goldfinger et al., 1998; Ebihara et al., 2000). 
Esco et al. (2001) suggested that the loss of processed Lm-332 may play a role in hypoxia-
mediated apoptosis of human corneal epithelial cells. Furthermore, a high glucose 
condition induces the inhibition of Lm-332 synthesis in HCE cells and may correlate to 
weakened epithelial cell adhesion and manifestation of diabetic keratopathy (Lu et al., 
2006).
Fibronectin is also present in corneal, limbal and conjunctival BM zones of human, rabbit 
and chicken eyes (Päällysaho and Williams, 1991; Tervo et al., 1986; Tuori et al., 1996; 
1997b). Of the fibronectin isoforms, EDA-Fn and Onc-Fn have been found in normal 
human corneal BMs (Tuori et al., 1996; 1997b). Several studies have shown that the 
expression of fibronectin increases during corneal wound healing (Fujikawa et al., 1981; 
Nickeleit et al., 1996; Tervo et al., 1991a; Ren et al., 1994; van Setten et al., 1992; Zhao et 
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al., 2003). PCR studies have substantiated this by demonstrating that the expression of 
alternatively spliced fibronectin mRNAs are upregulated during rat corneal epithelial 
wound healing (Cai et al., 1993; Vitale et al., 1994). In addition, fibronectin has been 
shown to promote epithelial cell migration in the cornea (Nishida et al., 1983). 
Tn-C, another multifunctional ECM glycoprotein, has been extensively studied and is 
found in the normal human and mouse corneal limbus, which is also the site of corneal 
epithelial stem cells (Tervo et al., 1990; Tuori et al., 1997b; Maseruka et al., 1997; Stepp 
and Zhu, 1997). Maseruka et al. (2000) showed that Tn-C participates in corneal 
development since it is expressed widely in the preterm cornea, but is restricted to the 
limbal area in child and adult corneas. Expression of Tn-C is increased in corneal 
inflammation, after refractive surgery and during restratification, suggesting a role for this 
glycoprotein in corneal inflammation, wound healing and ECM reorganization (Maguen et 
al., 1997; Maseruka et al., 1997; Stepp and Zhu, 1997; Tervo et al., 1991). In addition, its 
release is significantly increased in tear fluid after photorefractive keratectomy (Tervo et 
al., 1989; 1991; Stepp and Zhu 1997; Vesaluoma et al., 1995). Despite all of these results, 
its precise role in the cornea has remained elusive. Iglesia et al. (2000) showed that in Tn-
C knock-out mice it is not required for maintainance of the corneal limbus or normal re-
epithelization of corneal wounds. Similarly, the healing of cutaneous wounds was normal 
in Tn-C-deficient mice (Forsberg et al., 1996). Latijnhouwers et al. (1996) concluded that 
although tenascin is upregulated in skin wounds it is not a substrate for migrating 
keratinocytes. In healing skin wounds and corneal suture wounds of knock-out mice, 
however, the absence of Tn-C decreased the expression of fibronectin (Mackie and 
Tucker, 1999). The correlation between the expression of these ECM glycoproteins was 
also reported by Matsuda et al. (1999), who showed that in corneal suture wounds of mice 
Tn-C appears to increase the expression of fibronectin. Overall, the role of Tn-C in normal 
and wounded corneas has remained unclear and requires further examination.
Vitronectin, a multifunctional glycoprotein, is present in both plasma and ECM and is 
produced by hepatocytes and many other cells (Schvartz et al., 1999). Vitronectin is also 
expressed in human corneal BMs and binds to cell receptors by its RGD sequence (Xiao et 
al., 2005). Since tear fluid also contains this glycoprotein, corneal epithelial cells are 
exposed to it (Willcox et al., 1997). Vitronectin stimulates corneal epithelial cell migration 
as well as spreading of keratinocytes, which makes it a suitable subject for wound healing 
research (Brown et al., 1991; Nakamura et al., 1997).
Integrins ?2?1, ?3?1, ?6?1, ?6?4, ?v?1 and ?v?5 are expressed in the human corneal 
epithelium, mediating the attachment of corneal epithelial cells to the BM and ECM 
(Rayner et al., 1998; Tuori et al., 1996; Virtanen et al., 1992; for review, see Stepp, 2006). 
Of these integrins, ?6?4 is a component of hemidesmosomes (Borradori and Sonnenberg, 
1999), known to mediate the adhesion of HCE cells to Lm-332, in addition to integrin 
?3?1 (Nguyen et al., 2000; Ebihara et al., 2000). Studies with immortalized bovine and 
human corneal epithelial cells have shown that these cells are also capable of adhering to 
mouse Lm-111 and human placental laminin (Lms-511/521) via integrins ?3?1 and ?2?1
(Kurpakus et al., 1999). In defective human corneas, such as in diabetic and keratoconus 
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corneas, in vitro and in vivo studies have revealed an altered distribution of integrins ?3?1
and ?6?4, respectively (Kabosova et al., 2003; Tuori et al., 1997a). 
5.9.3 Corneal epithelial wound healing 
Adhesive interactions between the cells and the underlying ECM as well as cell-cell 
interactions are important during corneal wound healing. The basal limbal cells are 
thought to be stem cells, serving as a source of epithelial cells for the damaged corneal 
epithelium (Lavker et al., 2004; Zieske et al., 1992). Thus, early proliferative activity upon 
injury is observed in the limbal area and also among migrating corneal epithelial cells 
(Dua and Forrester, 1990; Ratkay-Traub et al., 2001). However, Zagon et al. (2000) 
discovered that re-epithelization of the corneal epithelium is particularly dependent on 
mitosis in the unwounded epithelium adjacent to the wound. To fully recover the corneal 
structure, epithelial cells migrate and cover the defective area, proliferate and differentiate 
(Suzuki et al., 2003). These processes are regulated by cytokines and growth factors, 
which are produced locally (Tervo et al., 1997; Vesaluoma et al., 1997; Wilson et al., 
1994).
After photorefractive keratectomy, the complete coverage of the corneal wound by 
epithelial cells is completed within 48-72 hours (Fagerholm et al., 2000). However, 
permanent anchoring requires a much longer time. Fountain et al. (1994) showed that after 
excimer keratectomy the human corneal anchoring fibrils do not recover completely even 
after 15 months. Certain clinical conditions, such as viral infections or diabetic 
keratopathy, can markedly alter normal wound healing. Corneal wound healing can be 
divided into three phases: latent phase, healing phase, including cell migration and 
proliferation, and permanent cell adhesion (Dua et al., 1994). In the latent phase, the 
desquamation of surface cells and the change in the columnar appearance of basal cells to 
cuboidal form occur. At the end of this phase, the leading wound edge consists of a single 
cell layer (Crosson et al., 1986). The loss of hemidesmosomes at the marginal cells of the 
wound is also an early event in wound healing (Ratkay-Traub et al., 2001).
One of the key features in the wound healing process is the synthesis of new proteins. 
During the latent phase, for instance, the amount of fibronectin increases transiently on the 
denuded corneal surface (Arffa and Eve, 1991; Fujikawa et al., 1981). Studies concerning 
refractive surgery show that fibronectin is synthesized after anterior keratectomy (Tanaka 
et al., 1999; Tervo et al., 1991). Fibronectin functions in the adhesion, spreading, 
migration and induction of FAs via integrins and is downregulated after wound healing 
(Fujikawa et al., 1981; Fukuda et al., 1990; Hynes,1992; Mooradian et al., 1993;
Nakagawa et al., 1990; Ohji et al., 1993; Suda et al., 1981; Suzuki  et al., 2003; Wang et 
al., 1994). Fibronectin is thus suggested to participate in the wound healing of the cornea 
(Cai et al., 1993; Murakami et al., 1992; Vitale et al., 1994). The fibronectin receptor 
integrin ?5?1 is upregulated during the healing process (Murakami et al., 1992; Nagakawa 
et al., 1990). Also Tn-C has been detected in the wound area, although its distribution is 
normally restricted to the limbus (Latvala et al., 1995; Tervo et al., 1991a). Furthermore, 
studies on healing alkali burns have shown that type IV collagen emerges into the BM of 
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the healing corneal epithelium and disappears later (Saika et al., 1995). Both corneal 
epithelial cells (Ohji et al., 1994) and stromal fibroblasts (Hassell et al., 1992) have been 
demonstrated to synthesize ECM and BM components in cell culture studies.
The adhesion between corneal epithelial cells is mediated by cell junctions including tight 
junctions, adherens junctions and desmosomes (McLaughlin et al., 1985). Each of these 
junctions has a distinct morphology, function and distribution in the stratified corneal 
epithelium. Gap junctions have been found in basal epithelial cells, tight junctions in 
superficial cells, desmosomes in wing cells located above basal cells and adherens 
junctions in all cell layers (Beuerman and Pedroza, 1996; Kapprell et al., 1988; Suzuki et 
al., 2000; Mohan et al., 1995; Wang et al., 1993). Gap and tight junctions as well as 
desmosomes disappeared from migrating corneal epithelial cells (McCartney and Cantu-
Crouch, 1992; Matic et al., 1997; Okada et al., 2001; Suzuki et al., 2000). In order to 
migrate, corneal epithelial cells must undergo repeated adhesion and de-adhesion cycles. 
MMPs, which belong to a family of ECM-degrading enzymes, are involved in the 
degradation of both BM and ECM macromolecules (Birkedal-Hansen, 1995). The
expression of MMP-1 and MMP-10 during re-epithelialization of human corneal wounds 
suggest a role for these MMPs in corneal epithelial cell migration (Daniels et al., 2003). In 
addition, changes in tear fluid plasminogen-plasmin activity have been reported to 
correlate with the corneal wound healing process (van Setten et al., 1989). Besides 
changes in cell junctions, cell-ECM interactions are crucial for corneal wound healing. 
The BM is often destroyed during corneal injury and the stroma is exposed to the external 
environment. The strong adhesion of basal corneal epithelial cells to the BM is ensured by 
hemidesmosomes, which disappear from the zone close to the wound margin (Crosson et
al., 1986; Latvala et al., 1996; Kenyon et al., 1977).
In vivo studies on corneal wound healing show that the cells of the leading edge present 
adherens junctions associated with bundles of actin filament and heal by the contractile 
“purse string” mechanism (Danjo and Gipson, 1998). However, Buck (1979) observed 
lamellipodia and filopodia along the leading wound edges. These leading edges have focal 
contacts. After wound closure, the basal cells proliferate and normal epithelial thickness is 
restored. Although new hemidesmosomes are established (Stock et al., 1992), Gipson et 
al. (1989) showed that in the rabbit corneal keratectomy wounds the reassembly of 
hemidesmosomes did not reach the normal state during the 12-month follow-up period. 
The corneal epithelial events during wound healing are presented in table 3.
Table 3. Corneal epithelial wound healing
 Latent phase Healing phase Permanent cell 
adhesion phase 
Epithelial events Desquamation of 
surface cells 
Single cell layer in 
the wound edge 
Epithelial cell adhesion, 
spreading and 
migration
Basal cell proliferation 
Epithelial cell 
differentiation
Hemidesmosomes
assemble
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6. AIMS OF THE STUDY
An avascular and clear cornea plays a major role in the refraction of the eye. Several eye 
diseases, injuries and refractive surgery can produce corneal wounds. Understanding and 
controlling the wound healing process require knowledge of the complex interactions of 
corneal epithelial cells with ECM components. The purpose of this study was to gain new 
information about human corneal epithelial cell interactions with BM and ECM proteins. 
To achieve this goal, we have investigated the role of laminins, fibronectins, tenascin-C 
and their integrin and non-integrin receptors in the adhesion, spreading and migration of 
immortalized human corneal epithelial cells. Specific aims of the study were as follows:
1. To elucidate the laminins present in human corneal BM and to determine those 
synthesized by corneal epithelial cells.
2. To determine the expression of laminin-, fibronectin-, Tn-C- and vitronectin-binding 
integrins on corneal epithelial cells and to identify which integrins mediate the adhesion of 
these cells to mouse Lm-111, human Lms-332 and -511, fibronectin, Tn-C and vitronectin. 
 3. To study the production and distribution of fibronectin isoforms and Tn-C in corneal 
epithelial cells. 
4. To assess the expression and distribution of non-integrin receptors in corneal epithelial 
cells and in corneal tissue.
5. To elucidate the role of non-integrin receptors for Lm-511 in adhesion of corneal 
epithelial cells.
6. To elucidate the role of BM and ECM proteins in early adhesion and migration of 
corneal epithelial cells. 
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7. MATERIALS AND METHODS 
7.1 Cell culture (I, II, III, IV) 
Simian virus-40 immortalized HCE cells were provided by Dr. K. Araki-Sasaki (Dept. of 
Ophthalmology, Osaka University School of Medicine, Osaka, Japan). HCE cells were 
cultured in D-MEM/F12 medium (Invitrogen Corp., Carlsbad, CA, U.S.A.) and 
supplemented with 15% fetal bovine serum, 5 ?g/ml insulin (Invitrogen Corp.), 0.1 ?g/ml
cholera toxin (Sigma, St. Louis, MO, USA), 10 ng/ml human epidermal growth factor 
(Invitrogen Corp.), 40 μg/ml gentamycin and 1 μg/ml glutamine (Invitrogen Corp.) (Araki 
et al., 1993). The cultures were maintained in 95% air and 5% CO2 at 37oC, and the cells 
were subcultured twice a week. In some experiments, the cells were exposed to 1-10 ?M
monensin (Lilly Research Laboratories, Indianapolis, IN, USA) for 1-2 h to overnight to 
stop secretion and induce the intracellular accumulation of secretory products (Tartakoff, 
1983).
Jar human choriocarcinoma cells were obtained from the American Type Culture 
Collection (Manassas, VA, USA), and human embryonic skin fibroblasts from a local 
source. Both of these cell lines were grown in RPMI-1640 medium (Sigma), supplemented 
with 10% fetal bovine serum and antibiotics.
7.2 Human corneas (I, III) 
Human corneal tissues were obtained from cadaver donors (Helsinki University Central 
Hospital, Helsinki, Finland), from the Department of Forensic Medicine (University of 
Helsinki, Helsinki, Finland; specimens kindly provided by Dr. Antti Tuori) or from 
penetrative keratoplasty performed at the University Hospital of Oulu (Oulu, Finland; 
specimens kindly provided by Dr. Marko Määttä). The central parts of the cadaver corneas 
were used in transplantation and only the peripheral parts were included in our studies. 
The specimens were frozen in liquid nitrogen and stored at -80ºC. Frozen sections were 
cut to 5-6 ?m, fixed in acetone, precooled to -20ºC for 10 min and subjected to 
immunohistochemistry. The study protocols were approved by the local ethics 
committees, and patients signed an informed consent. 
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7.3 Indirect immunofluorescence technique (I, II, III, IV) 
For indirect immunofluorescence experiments, HCE cells were first grown on glass 
coverslips and then fixed in either methanol at -20°C or 4% paraformaldehyde at room 
temperature for 10 min. After washing three times with phosphate-buffered saline 
containing 0.1% sodium azide (PBS azide), the cells were soaked in 0.125% Triton X-100 
in PBS azide and incubated with primary antibody for 30 or 60 min. All of the antibodies, 
including their specificity and sources, are listed in Table 4. The MAbs and PC antibodies 
were applied at a concentration of 2-4 µg/ml. The cells were washed again three times 
with PBS azide and soaked in 0.125% Triton X-100 with PBS azide. Finally, secondary
antibody was added for another 30 min. The following secondary antibodies were used: 
fluorescein isothiocyanate (FITC)- coupled goat antiserum against mouse or rat IgG, 
FITC-coupled rabbit antiserum against mouse or rat IgG, tetramethyl rhodamine 
isothiocyanate (TRITC)-coupled sheep antiserum against rabbit IgG and TRITC-coupled 
goat antiserum against rabbit or mouse IgG (all from Jackson Immunoresearch; West 
Grove, PA, USA). Additionally, in some experiments, Alexa Fluor-labelled goat antiserum 
against mouse (488) or rabbit IgG (594) was used (Molecular Probes, Eugene, OR, USA). 
All incubations were carried out at room temperature. Finally, the cells were embedded in 
Veronal-glycerol buffer (1:1; pH 8.4) or in 90% glycerol/10% Veronal buffer if subjected 
to confocal laser scanning microscopy. The cells were examined with a Leica Aristoplan 
microscope or an Olympus Provis fluorescence microscope, and the images were acquired 
using Analysis software (Soft Image Systems, Muenster, Germany) on a computer 
connected to a SensiCam 12 bit cooled imaging digital camera mounted on the 
microscope. Confocal laser scanning microscopy (CLSM) was carried out using a Leica 
TCS SP2 system with an argon excitation wavelength 488 nm and an HCX PL APO CS 
63x1.40 NA oil immersion objective. Image stacks were collected through the specimen 
using a standardized 120 nm z-sampling density. Selected image stacks were further 
subjected to deconvolution and restoration using theoretical point spread function and 
iterative maximum likelihood estimation algorithm (Scientific Volume Imaging BV,
Hilversum, the Netherlands). 
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Table 4. Antibodies and molecular probes used
Antibody Antigen 
specificity
PC/MC Dilution Reference Source 
Anti-hLN-α
1G4/G5
Laminin α1-
chain
PC  Tiger et al., 1997 D. Gullberg 
163DE4 Laminin α1-
chain
MC  Virtanen et al., 2000  
161EB7 Laminin α1-
chain
MC  Virtanen et al., 2000  
BM2 Laminin α3-
chain
MC,
FB
1:200 Rousselle et al., 1991 P. Rousselle 
12C4 Unprocessed 
laminin α3-
chain
MC  Goldfinger et al., 1999 J. Jones 
4C7 Laminin α5-
chain
MC  Engvall et al., 1986; 
1990
Tiger et al., 1997 
E. Engvall 
6F12 Laminin β3-
chain
MC  Marinkovich et al., 1992 R. E. 
Burgeson and 
P. Rousselle 
Pc Ln-5 Laminin-332 PC  I, this thesis  
TS 2/7 Integrin α1 MC  Hemler et al., 1984 M. E. Hemler 
CLB-10G11 Integrin α2 MC  Giltay et al., 1989 Netherlands 
Red Cross 
Blood
Transfusion
Service
PIE6 Integrin α2 MC,
FB
1:500 Wayner et al., 1988 Chemicon, 
Temecula,
CA
J143 Integrin α3 MC  Fradet et al., 1984 L. J. Old 
PIB5 Integrin α3 MC,
FB
1:500 Wayner et al., 1984 Chemicon 
Temecula,
CA
B1E5 Integrin α5 MC,
FB
1:5 Werb et al., 1989 Z. Werb 
GoH3 Integrin α6 MC,
FB
1:400 Sonnenberg et al., 1987 Netherlands 
Red Cross 
Blood
Transfusion
Service
Y9A2 Integrin α9 MC  Wang et al., 1996  
LM 142.69 Integrin αv MC  Cheresh and Spiro, 1987 D. A. Cheresh 
PIF6 Integrin αvβ5 MC,
FB
1:500 Wayner et al., 1988 Chemicon 
Temecula,
CA
E7P6 Integrin αvβ6 MC,
FB
1:500 Weinacker et al., 1994 Chemicon 
Temecula,
CA
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102DF5 Integrin β1 MC  Ylänne and Virtanen, 
1989
13 Integrin β1 MC,
FB
1:500 Yamada et al., 1990  
90BB10 Integrin β3 MC  Ylänne et al., 1988  
3E1 Integrin β4 MC  Hessle et al., 1984 Chemicon 
Temecula,
CA
AA3 Integrin β4   Tamura et al, 1990 V. Quaranta 
ASC-3 Integrin β4 MC,
FB
1:500 Pattaramalai et al., 1996 Chemicon 
Temecula,
CA
1A9 Integrin β5 MC  Pasqualini et al., 1993 D. Cheresh 
100EB2 Both isoforms 
of tenascin-C 
MC  Howeedy et al., 1990  
BC2 High molecular 
weight isoform 
of tenascin-C 
MC  Balza et al., 1993 L. Zardi 
Tenascin-X Tenascin-X PC  Hasegawa et al., 1997  
52DH1 EDA-
fibronectin
MC  Vartio et al., 1987  
BC-1 EDB-
fibronectin
MC  Carnemolla et al., 1989 L. Zardi 
FDC-6 Onc-
fibronectin
MC  Matsuura and Hakomori, 
1985
S-i Hakomori 
TA205 Talin MC   Serotec, 
Oxford, UK 
IIH6 α-dystroglycan MC  Ervasti and Campbell, 
1993
BD
Transduction
Laboratories
NCL-b-D6 β-dystroglycan MC   Novocastra, 
Newcastle
upon Tyne, 
UK
BRIC 221 Lutheran MC   Serotec, 
Oxford, UK 
D5B5 Laminin ?2-
chain
MC   Chemicon, 
Temecula,
CA; K. 
Miyazaki
To-Pro-3     Molecular 
Probes,
Eugene, OR
GM130 Golgi protein 
GM130
MC   BD 
Transduction
Laboratories
PC, polyclonal; MC, monoclonal; FB, function blocking
The concentration of function-blocking antibodies is 1 mg/ml. The dilutions are also 
provided.
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7.4 Field emission scanning electron microscopy (IV)
The cells were cultured on glass coverslips and fixed in 2.5% (w/v) glutaraldehyde 
(Sigma) in Na-cacodylate buffer (pH 7.2) for 1 h at 4ºC. After fixation, the samples were 
washed three times with the buffer. After dehydration in an increased series of ethanol,  
hexamethyldisilazane treatment was used as a final dehydration step (Bray et al., 1993; 
Nation 1983).
The specimens were mounted on aluminium or copper stubs with double-sided tape and 
silver glue. Chromium was used as a coating metal (20 ?M), and the sputter coating was 
performed in an EmiTech turbo sputter coater K575-X. All specimens were observed 
using a JEOL field emission scanning electron microscope (FESEM) JSM-6335F at 5-15 
kV (Tokyo, Japan). Some of the specimens were tilted up to 90°.
7.5 Purification of basement membrane and extracellular matrix proteins (I, II)
Affinity chromatography was used to purify Lm-332 from culture medium of BxPC-3 
pancreatic adenocarcinoma cells, as described in this section. The antiserum was obtained 
from rabbits immunized with Lm-332-rich ECM material, which the rat bladder carcinoma 
cell line 804G deposits (Hormia et al., 1995; Riddelle et al., 1991).
When Lm-332 was immunopurified from the culture medium of SCC25 cells, MAb 6F12 
against Lm ?3 chain was coupled to the Sepharose, and fibronectin was removed from the 
medium with gelatin-Sepharose prior to Lm-332 purification. One litre of each culture 
medium was first precipitated with 40% (NH4) 2SO4 at 4ºC overnight. After 
centrifugation, the pellets were dissolved in PBS and dialysed against PBS overnight at 
4ºC. The Sepharose beads and dialysed culture medium were pooled, and the beads were 
washed five times with PBS containing 0.5% Triton X-100 and 1 mM phenylmethyl- 
sulfonyl fluoride (PMSF). Bound proteins were eluated by using glycine buffer (pH 2.8) 
or acetate buffer (pH 11.3). Fractions containing Lm-332 were pooled and dialysed against 
PBS.
Human Lm-511 was purified from the culture medium of Panc-1 pancreatic carcinoma 
cells, which produce only Lm-511 (Tani et al., 1999), as described above. Sepharose-4B-
bound MAb DG10 (Virtanen et al., 1997) against Lm ?1 chain was used. Lm-511/521 
preparation was purchased from Sigma.
Fibronectin and vitronectin were purified from outdated human plasma (Finnish Red 
Cross Blood Transfusion Service, Helsinki, Finland), fibronectin by using gelatin-
Sepharose affinity chromatography (Amersham Pharmacia Biotech, Uppsala, Sweden), 
essentially according to Engvall and Ruoslahti (1977) and vitronectin by using heparin-
Sepharose (Amersham Pharmacia), according to Yatohgo et al. (1988). Purified Tn-C from 
U251Mg glioma cells was purchased from Sigma. 
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7.6 Immunoprecipitation, sodium dodecylsulphate polyacrylamide gel 
electrophoresis and fluorography (I, II, IV) 
For immunoprecipitation, HCE cells were incubated 30 min or 2 h in RPMI 1640 medium 
without serum and methionine and then labelled with 35S-methionine (50-100 ?Ci/ml;
Amersham Biosciences, Uppsala, Sweden) overnight at 37oC. When protein synthesis was 
studied during the early adhesion of HCE cells, the cells were trypsinized, trypsin- 
neutralizing solution (Promocell, Heidelberg, Germany) was added and the cells were 
incubated in methionine-free medium for 1 h. The 35S-methionine labelling was performed 
for 2 h at 37oC. The culture medium was then collected and the dead cells were removed 
by centrifugation. Triton-X-100 was added to a concentration of 0.5%. Prior to adding the 
antibodies, the culture medium was pre-cleared with normal mouse or normal rabbit serum 
bound to GammaBind Sepharose beads (Amersham Biosciences) to avoid background 
protein contamination. The cell-free ECM samples were obtained as follows: cell culture 
plates were washed three times with PBS, put on ice and treated for 3 x 10 min with 0.5% 
sodium deoxycholate (DOC) in a buffer containing 150 mM NaCl in 10 mM Tris and 1 
mM PMSF, pH 8. Finally, the plates were washed with 150 mM NaCl in 2 mM Tris and 1 
mM PMSF, pH 8. Solubilization of cells was performed by adding 
radioimmunoprecipitation (RIPA) salts and 0.1% sodium dodecyl sulphate (SDS). The 
supernatants were collected, centrifuged for 15 min at 4oC and boiled for 3 min. DOC and 
Triton-X-100 were added to a concentration of 1%. The clearing was performed as 
described above. After centrifugation, the supernatants were removed and 
immunoprecipitated overnight with antibodies prebound to GammaBindR SepharoseR
beads. The beads were then washed four times with PBS containing 0.5% Triton X-100 
and 1 mM PMSF or RIPA salts. The controls were prepared by precipitating 
GammaBind® Sepharose® beads only. Finally, the proteins were solubilized in 
Laemmli’s sample buffer and heated 5 min at 90oC. For SDS-PAGE, 5% or 6.5% slab gels 
were prepared. The gels were loaded with 70 µl of protein samples. High molecular 
protein weight standards (Amersham Biosciences) were used in all experiments. Finally 
the gels were dried and subjected to fluorography.
7.7 Western blotting (I, II) 
HCE cells were first cultured in serum-free HCE cell culture medium overnight, and 
ammonium sulphate-precipitated protein samples were then solubilized and separated by 
SDS-PAGE as described above. The gels were loaded with 100 µl of protein samples. The 
separated proteins were then transferred to a nitrocellulose membrane electrophoretically 
and monitored by Ponceau S staining. Remaining hydrophobic binding sites on the 
membrane were blocked by using 3% BSA in PBS azide or 5% non-fat dried milk in PBS. 
The membrane was incubated with the primary antibody (2-4 µg/ml) for 1 h at room 
temperature and washed with 0.01% Tween in PBS. Finally, the biotin-labelled secondary 
antibody was added to the blot for 30 min, and after washing with 0.01% Tween in PBS, 
the avidin biotin complex was added (VectastainR; Vector Laboratories, Burlingame, CA, 
USA) for 1 h. The bands were detected by using 3,3'-diaminobenzidine (DAB; Sigma), 
and the reaction was terminated with milli-Q-purified water. 
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7.8 Northern blotting (III) 
Total RNA of HCE cells was isolated by using Trizol® (Invitrogen), which contains 
phenol and guanidine isothiocyanate, or according to the method of Chomczynski and 
Sacchi (1987). Trizol, which disrupts the cells and dissolves cell components, was added 
to the cells prior to addition of chloroform. After centrifugation, the aqueous phase 
containing the RNA was collected and precipitated with isopropyl alcohol. Finally, the 
RNA was washed with 75% ethanol and dissolved in distilled DEPC-treated water.
By using Dynabeads Oligo (dt)25-beads (Dynal, Oslo, Norway), mRNA was purified from 
isolated total RNA. Then 75 ?g of total RNA was adjusted to a volume of 100 ?l of 
distilled DEPC-treated water and heated to 65oC for 2 min. The Dynabeads Oligo (dT)25-
beads were washed according to the manufacturer`s instructions, and  total RNA was 
added to the Eppendorf tube containing the dynabeads. After a 5-min rotation at room 
temperature, the supernatant was removed. The dynabeads were washed twice, and elution 
of mRNA (ca. 2µg) was performed by adding 10 ?l of 10 mM Tris-HCl and heating to 
85oC for 2 min. 
The mRNA samples were prepared by adding 10 x 3-N-morpholino propanesulphonic acid 
(MOPS) running buffer, formaldehyde and formamide, following by incubation at 65oC
for 5 min and quick chilling in an ice bath. The mRNAs were then separated according to 
their size by 1% agarose-formaldehyde gel electrophoresis (Agarose NA; Amersham 
Biosciences) at 40 V for 3.5 h. Treatment with formaldehyde disrupts the hydrogen bonds 
between base pairs and denatures the mRNA samples. Upward capillary transfer was used 
to transfer the mRNAs from the gel to a Hybond N nylon membrane (Amersham 
Biosciences), and the mRNAs were crosslinked.
A plasmid containing the full-length human Lu coding region was modified as described 
by Kikkawa et al. (2002). A 700 bp Lu probe was generated by restriction with SmaI 
(Promega, Madison, WI, USA) and labelled with a Dig High Prime DNA Labelling and 
Detection Starter Kit II (®Roche Diagnostics, Mannheim, Germany). The DIG-labelled 
DNA probe was denaturated by boiling for 5 min and cooling in ice. Prehybridization and 
hybridization were performed at 55°C in high SDS hybridization solution, and the 
membrane was incubated with the probe/hybridization mixture overnight. Finally, 
immunological detection was performed, and the membrane was exposed to Hyperfilm 
MP (Amersham Biosciences). A 0.28-6.58 kb RNA ladder (Promega) was used to 
determine the transcript size.
7.9 Morphological cell adhesion experiments (III, IV) 
For morphological cell adhesion studies, glass coverslips were coated with Lm-511 (4 
μg/ml; purified as described in Section 7.5), fibronectin (4 μg/ml; purified as described in 
Section 7.5), Tn-C (4 μg/ml; Sigma), vitronectin (4 μg/ml; purified as described in Section 
7.5) or the combination of these proteins at room temperature for 4 h. The glass coverslips 
were then washed twice with PBS and postcoated with 3% bovine serum albumin in PBS 
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at room temperature for 1 h. In some experiments, the cells were incubated with 
cycloheximide (10 µg/ml; Sigma) at 37°C for 1 h to inhibit protein synthesis. After the 
addition of trypsin and soybean trypsin inhibitor (STI; Sigma) or trypsin-neutralizing 
solution (TNS; Promocell), the cells were suspended in serum-free culture medium with or 
without cycloheximide (10 µg/ml) and centrifuged for 5 min. The supernatant was 
removed and the cells were suspended in the same medium with or without 
cycloheximide. Finally, HCE cells were seeded for 1, 2, 3, 4 or 16 h on coated or plain 
glass coverslips at 37°C. In some experiments, cytochalasin-B (5 ?g/ml, Sigma) or 
demecolcine (5 ?g/ml, Sigma) was used to disrupt microfilaments and microtubules, 
respectively. After the cells were fixed in methanol at -20oC, they were subjected to 
indirect immunofluorescence. 
For in vitro wounding experiments, HCE cells were trypsinized and trypsin-neutralizing 
solution was added. The cells were washed with D-MEM/F12 medium and suspended in 
the same medium. HCE cells were seeded and allowed to grow on glass coverslips at 
37°C. Confluent HCE cell layers were wounded by scraping with a rubber policeman and 
allowed to migrate for 12 h. 
7.10 Quantitative cell adhesion assays (I, II, III, IV) 
Cell adhesion experiments were performed by detecting intracellular acid phosphatase 
activity (Prater et al., 1991; see Tani et al., 1999). The 96-well plates were coated with 
laminins, pFn (purified as described in Section 7.5), vitronectin (purified as described in 
Section 7.5) or Tn-C (Sigma). The applied concentrations of the coating proteins were 2-4 
?g/ml. Some wells were left without coating. After a 1-h incubation at room temperature, 
the wells were washed twice with PBS and some cells were exposed to recombinant 
soluble-Lu (Sol-Lu; 10 ?g/ml; Kikkawa et al., 2002). For postcoating, 3% bovine serum 
albumin in PBS was added for 1 h, and finally, the wells were washed twice with PBS. 
Some cells were incubated with cycloheximide (10 ?g ml/ml) at 37oC for 60 or 90 min, 
and all cells were trypsinized and TNS or soybean trypsin inhibitor (Sigma) was added. 
The cells were washed once with serum-free D-MEM/F12 medium and suspended in the 
same medium in the presence or absence of cycloheximide. The function-blocking MAbs 
are listed in Table 4. The MAbs were used at concentrations of 2 - 4 μg/ml to inhibit cell 
adhesion. Cell-antibody suspension was added to each well containing 20 000 cells and 
incubated at 37oC for 60-90 min. In a set of experiments, GRGDSP peptide (Sigma) was 
used at concentrations of 100 - 500 μg/ml to inhibit adhesion. The plates were washed 
three times with PBS, and 100 ?l of the following substrate/lysis solution was added to 
each well: phosphatase substrate solution (6 mg ml/ml, Sigma) in 50 mM sodium acetate 
buffer (pH 5) containing 1% Triton-X100. The plates were incubated at 37oC for 1 hr and 
the reaction was stopped by adding 50 ?l of 1 M NaOH to each well. Finally, the air 
bubbles were removed and the absorbances were measured by an enzyme-linked 
immunosorbent assay plate reader with a 405 nm filter. Each adhesion experiment was 
performed with triplicate wells, and standard deviations were calculated to evaluate 
variations between absorbances. 
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8. RESULTS AND DISCUSSION 
8.1 Corneal distribution and production of laminins by human corneal epithelial 
(HCE) cells
8.1.1 Laminin composition of adult human corneal basement membrane (I) 
Previously, the BM of the human cornea has been considered to express Lms-111 and -
332 (Ljubimov et al., 1995; 1998; Tuori et al., 1996; 1997a). We clarified the laminin 
composition of adult human corneal BM by subjecting frozen sections of human cornea to 
MAbs against Lm ?1, ?3 and ?5 chains. Immunoreactivities for only Lm ?3 and ?5 chains 
were found in these specimens, suggesting the presence of Lms-332 and -511 in human 
corneal BMs. Our result was obtained with our novel MAbs and also with the same 
polyclonal (PC) antiserum against the Lm ?1 chain that was used in the aforementioned 
studies. These results are in accordance with earlier ones showing that the Lm ?1 chain is 
not expressed in BMs of human stratified epithelia (Virtanen et al., 2000). This finding is 
also consistent with the results of Byström et al. (2006) showing that the Lm ?1 chain is 
expressed in BM of fetal human cornea up to embryonic week 12.
8.1.2 Production of laminins and deposition of laminin-332 by HCE cells (I) 
The re-estimation of corneal BM laminin composition led us to further investigate the 
production of laminins by HCE cells. We used an HCE cell line, which resembles normal 
HCE cells and is easy to maintain (Araki-Sasaki et al., 1995). We did not succeed in 
properly maintaining in culture normal HCE cells that were repeatedly purchased from 
commercial sources (Cascade Biologics, Portland, OR, USA). The proteins in the culture 
medium of radioactively labelled HCE cells were analysed by using immunoprecipitation, 
SDS-PAGE and fluorography. These experiments with specific MAbs and with PC 
antiserums showed that HCE cells synthesize unprocessed Mr 190 kD ?3 chain (?3’),
processed Mr 165 kD Lm ?3 chain (?3) and Mr 140 kD Lm ?3 chain as well as 
unprocessed Mr 155 kD Lm ?2 chain (?2’) and Mr 105 kD processed Lm ?2 chain (?2). In 
addition, the culture medium of HCE cells and the cell-free ECM preparation were 
subjected to Western blotting, and antiserum against Lm ?2 chain was used. Again, the 
presence of Mr 155 kD Lm ?2’ and Mr 105 kD Lm ?2 chains were detected. We then 
studied the deposition of Lm-332 in HCE cell cultures by using the indirect 
immunofluorescence technique. Already after 1 h of adhesion, Lm-332 was observed as 
small plaques beneath the adhering cells. After 4 h, Lm-332 was seen as diffuse plaque-
like structures in cell cultures. At this stage, a partial colocalization was found for 
immunoreactivities of Lm-332 and intergrin ?6?4.
HCE cells did not, however, produce Lm ?1 or ?5 chains. For positive control, Jar human 
chorioncarcinoma cells were also immunoprecipitated. Indeed, these cells produced Mr
400 kD Lm ?1 chain and Mr 380 kD Lm ?5 chain. These results agree with earlier studies 
that have shown that epithelial cells produce Lm-332 (Ebihara et al., 2000; Rousselle et 
al., 1991; Marinkovich et al., 1992; Pierce et al., 1998). Even though Lm-511 was present 
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in corneal BM and gingival epithelial cells and pulmonary alveolar epithelial cells have 
been demonstrated to synthesize Lm ?5 chain (Pakkala et al., 2002; Pierce et al., 1998), 
HCE cells did not apparently secrete this laminin. Since earlier studies have suggested that 
keratocytes might be the origin of corneal BM components (Gipson et al., 1989; Hassell et 
al., 1992; Tanaka et al., 1999), we proposed that stromal keratocytes synthesize Lm-511.
8.2 Role of laminins and their receptors in HCE cells
8.2.1 Distribution of laminin-binding integrin receptors in HCE cells (I, II) 
To analyse the role of corneal laminins, we first had to clarify the integrin receptor 
repertoire of HCE cells. Integrins are involved in both cell adhesion and migration by 
binding to BM and ECM proteins and by mediating mechanical forces and regulating the 
cytoskeletal organization (Ingber, 1997; Sheetz et al., 1998). Earlier studies have shown 
that the human corneal epithelium expresses integrins ?2?1, ?3?1, ?v?1, ?v?5, ?6?1 and 
?6?4, which are known to serve as laminin receptors (Lauweryns et al., 1991; Stepp, 
2006; Stepp et al., 1990; 1993; Tervo et al., 1991b; Virtanen et al., 1992; Vorkauf et al., 
1995). We also found all of these integrins in HCE cell cultures, showing that in this 
respect HCE cells resemblel normal corneal epithelium. MAb against the integrin ?2
subunit reacted heterogeneously with cell surfaces. An overall weak immunoreactivity 
was seen, yet some cells showed a brighter reaction. Immunostaining for the integrin ?3
subunit revealed a more even cell surface-confined immunoreactivity. Both integrin ?6
and ?4 subunits showed a leopard skin-like immunoreactivity, as reported in previous 
studies on human keratinocytes (Marchisio et al., 1991). The integrin ?1 subunit gave an 
even cell surface reaction and also confined to nail-like focal adhesions. In addition to 
integrins and actin terminations, these adhesive contacts also contain various actin-
associated and signalling proteins (David et al., 1999; Geiger et al., 2001; Zamir and 
Geiger, 2001). Immunoreactivity for integrin ?3 subunit, a component of laminin-511 
binding integrin ?v?3 (Genersch et al., 2003), has not been found in corneal epithelium 
(Lauweryns et al., 1992; Rayner et al., 1998; Tervo et al., 1991b), and was not observed in 
HCE cells either.
8.2.2 Expression and distribution of laminin-binding non-integrin receptors in 
HCE cells (III) 
Among the non-integrin laminin receptors, both Lu (El Nemer et al., 1998; Udani et al., 
1998) and the dystroglycan-glycoprotein complex (Yu and Talts, 2003) have been shown 
to serve as receptors for ?5 chain laminins. We first explored the expression of these non-
integrin receptors in HCE cells and then studied their role in the adhesion of HCE cells. 
To determine whether HCE cells express Lu mRNA transcripts, Northern blotting analysis 
was used. This experiment revealed the presence of both 4.0 kb and 2.8 kb bands of Lu 
mRNA. The presence of Lu protein was also investigated in human corneas as well as in 
HCE cells. The peripheral parts of corneas available for this study showed a bright basal 
cell-confined immunoreaction to Lu. In cultured adhering and subconfluent HCE cells, a 
punctate diffuse immunoreaction was found for Lu on cell surfaces. The presence of ?-
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and ?-dystroglycan was examined in vivo and in vitro. No immunoreaction was detected 
with MAbs for these proteins.
8.2.3 Adhesion of HCE cells to laminins (I, II, III) 
The adhesion characteristics of HCE cells to laminins were exposed. This is an extremely 
interesting subject since cell adhesion and de-adhesion are both essential but not very 
well- studied processes in corneal wound healing. Recently, amniotic membrane 
transplantation for defective corneas has been an active area of research (Tseng, 2001). 
This technique is currently used clinically in corneal epithelial ulcerations, limbal stem 
cell deficiency and chemical burns (Anderson et al., 2001; Arora et al., 2005; Lee and 
Tseng, 1997). One focus in the field of amniotic membrane transplantation has been its 
BM composition and the interaction of BM proteins with corneal epithelial cells 
(Kurpakus-Wheater, 2001).
Purified human Lms-332 and -511 were included in the adhesion experiments since both 
are present in human corneal BM. The adhesion characteristics to mouse Lm-111 were 
also investigated. The function blocking MAbs against integrins were chosen according to 
the integrin composition of HCE cells and previous studies concerning the binding 
properties of the aforementioned laminins via integrin receptors. Previously, HCE cells 
have been shown to adhere more efficiently to human placental laminin (Lm-511/521) 
than to mouse Lm-111 (Kurpakus et al., 1999). Furthermore, Kurpakus et al. (1999) 
suggested that HCE cells adhere mainly via integrin ?3?1, less via integrin ?2?1 and not 
at all via integrin ?6?1 to EHS and placental laminins. In contrast, we found that only the 
integrin ?1 subunit mediated the adhesion of HCE cells to mouse Lm-111, while integrin 
?2, ?3 and ?6 subunits did not function in this adhesion. Whether a new integrin ? subunit 
exists that mediates HCE cell adhesion to Lm-111 remains to be elucidated. Several 
studies have shown that epithelial cells adhere to Lm-332 via integrin ?3?1 (Carter et al., 
1991; Ebihara et al., 2000; Nguyen et al., 2000;  Rousselle and Aumailley, 1994). Our 
results indicated that integrin ?3?1 functions in the adhesion of HCE cells to Lm-332, and 
this integrin mediated the adhesion of HCE cells to Lm-511. Pouliot et al. (2002) have 
studied the adhesion of human keratinocytes to Lm-511/521. Their results suggest that 
human keratinocytes utilize both integrin ?3?1 and ?6?1 in this adhesion. On the other 
hand, in our study, integrins ?2?1 and ?6?4 did not function in the adhesion of HCE cells 
to any of the tested laminins. The results also showed that MAbs against integrins ?3 and 
?1 as well as MAb BM2 against Lm ?3 chain partially inhibited the adhesion of HCE cells 
to newly deposited Lm-332 beneath the cells.
Lu has been reported to be a potent non-integrin receptor for the Lm ?5 chain (Kikkawa 
and Miner, 2005; Kikkawa et al., 2002: Parsons et al., 2001). The adhesion of HCE cells 
to Lm-511 was evaluated in the presence of cycloheximide, which prevents endogenous 
protein synthesis. These studies revealed that Lm-511 appears to enhance the spreading of 
HCE cells. Furthermore, immunoreactivities for Lu and talin were found in the diffuse 
punctuate pattern on HCE cells adhered to Lm-511. Immunoreactivity for Lu remained 
cell surface-confined and diffuse in HCE cells adhered to fibronectin or to fibronectin and 
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Lm-511. On the basis of these results, we suggest that the adhesion of HCE cells to Lm-
511 does not induce Lu into FAs. Our experiments under similar adhesion conditions 
show that fibronectin promotes FA formation, thereby excluding the possibility that 
cycloheximide would prevent the formation of these adhesion structures. Previous studies 
suggest that the intermediate state of adhesion includes ECM ligand-induced integrin 
clustering and cell spreading but not FAs (Murphy-Ullrich, 2001). This state of adhesion 
is considered to support cell survival and to be the most favourable for cell motility. We 
therefore suggest that Lm-511 serves as an ECM ligand, enabling HCE cell motility. 
However, the fact that talin assembled into FAs in HCE cells adhering to Lm-511 together 
with Fn shows that Lm-511 does not prevent FA formation. Kikkawa et al. (2003) showed 
that Sol-Lu inhibited the adhesion of mesangial cells to Lm-511 only together with MAb 
against integrin ?3?1 and had only little inhibitory effect on its own. We found that Sol-
Lu, which is a recombinant protein containing the Lu-receptor extracellular domain and 
which saturates the Lu binding site of the Lm ?5 chain (Kikkawa et al., 2003), 
significantly inhibited the adhesion of HCE cells to Lm-511. This inhibition was not 
enhanced with MAbs against integrin ?3 or ?1. Our findings can be explained by the 
binding sites for Lu and integrin ?3?1 overlapping in the Lm ?5 LG1-3 modules (Kikkawa 
et al., 2003; Yu and Talts, 2003). Sol-Lu also inhibited the adhesion of HCE cells to the 
Lm-511/521 preparation, and the effect was increased when cycloheximide was applied to 
inhibit endogenous Lm-332 synthesis. Sol-Lu failed to inhibit HCE cell adhesion to Lm-
332, thereby suggesting that Lu is a specific receptor for the Lm ?5 chain. 
8.3 Production, secretion and deposition of tenascin-C and fibronectin isoforms by 
HCE cells (II) 
Since the purpose of this study was to clarify the roles of BM and ECM proteins in the 
cornea, we investigated the production, secretion and deposition of Tn-C and fibronectin 
by HCE cells. The adhesive properties of fibronectin, vitronectin and the adhesion 
modulating role of Tn-C were also considered. The deposition of Tn-C and fibronectins by 
cultured HCE cells was examined by using an immunofluorescence technique. MAbs 
against EDA- and Onc-Fn yielded a bright cell surface–associated fibrillar 
immunoreactivity, while immunoreactivity for EDB-Fn was lacking in HCE cells. MAbs 
against both subunits of Tn-C and Tn-CL gave a similar diffuse patch-like immunoreaction 
beneath the cells. Tuori et al. (1999) showed that Tn-X was also present in the corneal BM 
of rats and humans, but we did not find this glycoprotein in HCE cells. 
While studies have revealed that fibronectin is produced by stromal and epithelial cells in 
healing corneas (Nickeleit et al., 1996; Phan et al., 1989; Vitale et al., 1994), the origin of 
Tn-C under these circumstances remains unsolved. However, during wound healing of 
human skin, epidermal keratinocytes express and are a source of Tn-C (Aukhil et al., 
1996; Latijnhouwers et al., 1997). To obtain data on the production of fibronectin and Tn-
C isoforms in HCE cells, we used Western blot analysis of the culture medium and cell-
free ECM. Radioactive metabolic labelling was first applied, but a strong unspecific 
precipitate with Mr 190-250 kD was consistently found in the gels. In Western blotting, 
EDA-Fn and Onc-Fn were both present in the culture medium of HCE cells and cell-free 
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ECM with Mr 240 kD. However, the reaction with MAb against Onc-Fn was much 
weaker. MAbs against both subunits of Tn-C and Tn-CL showed a band of Mr 290 kD in 
cell-free ECM, but not in the culture medium of HCE cells. Furthermore, a weak band of 
Mr 190 kD was detected in cell-free ECM with MAb against both subunits of Tn-C. ECM 
produced by human embryonic fibroblasts was used as a control and showed a Mr 240
band with MAb against Onc-Fn. Tn-C purified from the culture supernatant of U251Mg 
glioma cells was also used as positive control and showed both subunits of Tn-C. These 
results indicate that HCE cells produce two fibronectin isoforms and Tn-CL, suggesting 
that corneal epithelial cells could also produce these ECM glycoproteins in wound 
healing.
Because Tn-C was only found in ECM, we suggested that it is vectorially deposited and 
uses different secretory pathway than fibronectin isoforms. This was partially confirmed 
by exposing HCE cell cultures to monensin, a monovalent ionophore, which stops 
secretion and induces accumulation of intracellular secretion granules (Tartakoff, 1983). 
Double immunostaining for fibronectin and Tn-C showed that these ECM glycoproteins 
appeared to be located to different cytoplasmic granules.
8.4 Role of extracellular matrix glycoproteins and their integrin receptors in HCE 
cells
8.4.1 Distribution of fibronectin-, tenascin-C- and vitronectin-binding integrins in 
HCE cells (I, II) 
To obtain data for adhesion experiments, we first investigated the content of integrins in 
HCE cell cultures by indirect immunofluorescence. Previous studies have suggested that 
corneal epithelial cells would adhere to fibronectin via the following integrins: ?3?1,
?6?1, ?6?4, ?9?1, ?v?1 and ?v?6 (for a recent review, see Stepp, 2006). Of these, integrin 
?9 and ?6 subunits were not found in HCE cell cultures. Integrin ?5?1 functions as a 
fibronectin receptor in epidermal keratinocytes (Clark, 1990). Although integrin ?5
subunit has only been observed in rat, not human, corneas (Stepp et al., 1993; Tervo et al., 
1991b), we identified this integrin subunit in FAs and cell surface-associated ECM 
adhesions in HCE cells. Studies concerning corneal wound healing show that integrins 
?v?6 (Hutcheon et al., 2005) and ?9?1 (Stepp and Zhu, 1997) are upregulated during 
corneal injury. These integrins are known to serve as corneal epithelial cell receptors for 
vitronectin and Tn-C, respectively (Stepp, 2006). Additionally, vitronectin has been shown 
to be a ligand for at least integrins ?v?1, ?v?3 and ?v?5 (Plow et al., 2000). The 
immunoreactivity for integrin ?1 and ?3 subunits in HCE cell cultures remained negative. 
MAbs against integrin ?v and ?5 subunits gave similar reactions, both showing point and 
peculiar ring-like structures on the cell centres and FAs in the peripheral cells of cell 
islands in sparce HCE cell cultures. In dense cultures, however, these MAbs showed only 
ring-like structures on the substratum-adhered side of the cells. 
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8.4.2 Morphology of the HCE cells adhering to fibronectin, tenascin-C and 
vitronectin (II)
The spreading of HCE cells as well as their integrin receptors were studied during HCE 
cell adhesion to ECM proteins by indirect immunofluorescence. For this purpose, HCE 
cells were seeded on fibronectin-, Tn-C-, vitronectin- and fibronectin/Tn-C-coated 
substrata. The cells spread on both fibronectin- and fibronectin/Tn-C-coated substrata 
within 1 h. Less spreading was observed on vitronectin-coated growth substratum, and no 
spreading on plain Tn-C coating. The latter finding is in line with results showing that 
cultured keratinocytes adhere poorly to Tn-C, thereby suggesting that Tn-C does not serve 
as an adhesive substrate for migrating keratinocytes (Latijnhouwers et al., 1997). HCE
cells that were plated on plain glass coverslips spread slowly.
Our adhesion experiments showed that integrins ?5, ?1 and ?v?6 were localized in the 
FAs within 1 hour in HCE cells adhering to fibronectin. When HCE cells spread on 
fibronectin/Tn-C coated substratum, integrins ?5, ?v and ?6 remained localized to the 
FAs. We therefore suggest that Tn-C does not downregulate fibronectin-induced FA 
formation in HCE cells as it does in fibroblasts (Midwood and Schwarzbauer, 2002). No 
reactivity was found with MAbs against integrin ?3 or ?5 subunits on fibronectin or 
fibronectin/Tn-C coating. Cell surface-confined spots were observed with MAbs against 
integrin ?v and ?5 subunits on HCE cells adhered to vitronectin. Previous studies with 
different cell lines report a similar distribution of integrin ?v?5 on the vitronectin coat 
(Wayner et al., 1991). Wayner et al. (1991) concluded that the intracellular portion of the 
?5 subunit does not associate with the actin cytoskeleton or associates with other 
cytoplasmic proteins and thereby appears as spots. Immunoreactivity for integrin ?1, on 
the other hand, showed a diffuse reaction in HCE cells on the vitronectin coat. 
Immunoreactivity for integrin ?5, ?9, ?3 and ?6 subunits remained negative in HCE cells 
on this substratum.
8.4.3 Quantitative cell adhesion experiments of HCE cells adhering to fibronectin, 
tenascin-C and vitronectin (I, II, IV) 
Previous studies concerning mostly epithelial cells have suggested that integrin ?3?1
would be a promiscuous receptor for fibronectin, laminin and collagen (Plow et al., 2000; 
Wayner and Carter, 1987). We obtained similar results when we studied the adhesion of 
HCE cells to fibronectin, which was inhibited with function-blocking antibody against 
integrin ?3?1. However, when cycloheximide was applied to inhibit endogenous protein 
synthesis during the adhesion process, only MAbs against integrin ?5 and ?1 subunits 
inhibited the adhesion to fibronectin, and no inhibition was seen with MAb against 
integrin ?3. The result led us to propose that integrin ?3 actually binds to endogenously 
deposited Lm-332 under normal cell adhesion conditions. This suggestion was supported 
by earlier observations with human keratinocytes indicating that integrin ?3?1 is a 
receptor for Lm-332 (Zhang and Kramer, 1996) and not for Fn (Eble et al., 1998). We 
confirmed this hypothesis by allowing HCE cells to secrete and adhere to endogenous Lm-
332. Under these circumstances, MAbs against integrin ?3 and ?1 subunits as well as 
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MAb BM2 against the Lm ?3 chain partially inhibited the adhesion to an uncoated 
substratum. Evidence supporting the idea that endogenously produced Lm-332 interferes 
with the adhesion experiments emerged from HCE cells adhering to purified Tn-C only in 
the absence of cycloheximide. Under these circumstances, the cells adhere to endogenous 
Lm-332. Although MAb against integrin ?v?6 did not inhibit adhesion to fibronectin 
alone, the inhibition was nearly complete when MAb against integrin ?v?6 was applied 
together with function-blocking MAb to the integrin ?5 subunit. HCE cells adhered 
similarly to fibronectin/Tn-C-coated wells as to fibronectin; however, in the presence of 
Tn-C MAbs against integrin ?5 and ?1 functioned more effectively. Because both of these 
ECM proteins are produced during wound healing, we suggest that fibronectin and Tn-C 
cooperate during the adhesion and migration of epithelial cells. However, further studies 
are needed to thoroughly understand this mechanism. In some adhesion experiments, RGD 
peptide was used at concentrations of 100 ?g/ml and 500 ?g/ml. Although RGD peptide 
(500 ?g/ml) inhibited HCE cell adhesion to fibronectin, the inhibition was much higher at 
both concentrations of RGD peptide when the cells adhered to the fibronectin/Tn-C coated 
substratum. This result indicates that Tn-C modulates the adhesion characteristics of HCE 
cells to fibronectin. HCE cells adhered also to the vitronectin-coated substratum, and this 
adhesion was inhibited with RGD peptide as well as with MAbs against integrin ?1 and 
?v?5. When cycloheximide was applied, the adhesion-blocking effect of these MAbs and 
RGD peptide increased significantly. The integrin ? subunit that mediates HCE cell 
adhesion to vitronectin with integrin ?1 remained unsolved, most likely however being 
integrin ?v?1 (Marshall et al., 1995). 
8.5 Role of laminin-3’32/332 and tenascin-C in the early adhesion, spreading and 
migration of HCE cells (IV) 
We were particularly interested in the events occurring during early adhesion, spreading 
and migration of HCE cells, which might reflect true phenomena during corneal wound 
healing. Numerous studies have shown that Lm-332 functions in these processes in 
different human epithelial cell lines (Baker et al., 1996; Frank and Carter, 2004; Hormia et 
al., 1995; Nguyen et al., 2000; Rousselle and Aumailley, 1994) as well as in HCE cells 
(Ebihara et al., 2000; Qin and Kurpakus, 1998). Kaplony et al. (1991) suggested that also 
Tn-CL facilitates corneal epithelial cell migration in the embryonic cornea. Furthermore, 
the amount of Tn-C increases in tear fluid and in corneal stroma during wound healing 
(Tervo et al., 1991a; Vesaluoma et al., 1995). We have already shown that HCE cells 
produce both Lm-332 and Tn-C. Whether these proteins are also produced and deposited 
during the early adhesion of HCE cells was one of the major questions.
8.5.1 Adhering and spreading HCE cells – cell morphology and deposition of 
proteins (IV) 
The morphology of adhering and spreading HCE cells was first studied by using FESEM. 
The 90º tilting angle of the cell culture combined with a very small adhesion area of 
roundish cells caused some charging problems during the scanning of the beam. The 
deposited proteins were detected by indirect immunofluorescence, and the data was 
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combined with FESEM results according to the adhesion time of HCE cells. After 1 h of 
adhesion, foot-like processes appeared to protrude from the basal aspect of the cells, and 
already at this stage a spot-like Tn-CL plaque was found beneath the adhering cells. The 
small processes converted into a larger circular area within 1-2 h of adhesion, and small 
microspikes or filopodia concurrently became attached to the growth substratum. After 1.5 
h of adhesion, many of the cells showed asymmetrical lamellipodia-like structures, and 
also the Tn-CL plaque was asymmetrically situated beneath the rounded cell body. 
Eventually, the cells extended wide symmetrical lamellipodia, and a large Tn-CL plaque 
was seen beneath the cells. Double immunostaining showed that Lm-332 colocalized with 
Tn-CL plaques beneath HCE cells as round or oval plaques during the first 1-2 h of 
adhesion. After 4 h of adhesion, however, the adhesion plaques were wide, extending 
diffusely beneath the cells. The colocalization of Tn-CL and Lm-332 was confirmed by 
double immunoreaction CLSM images. Based on these results we suggest that both Tn-CL
and Lm-332 functions in HCE cell adhesion.
8.5.2 Adhering and migrating HCE cells – role of laminin-332 isoforms (IV) 
Lm-332 isoforms were studied by indirect immunofluorescence to evaluate their role in 
adhesion, spreading and migration of HCE cells. Previously, Lm-3’32 has been shown to 
promote keratinocyte and corneal epithelial cell motility via integrin ?3?1, while Lm-332 
functions in the formation of hemidesmosomes and inhibition of cell migration via 
integrin ?6?4 (Ebihara et al., 2000; Goldfinger et al., 1998; Hintermann and Quaranta, 
2004; Marinkovich et al., 1992; Nguyen et al., 2000). Furthermore, Qin and Kurpakus 
(1998) demonstrated that endogenously secreted Lm-3’32 promotes epidermal growth 
factor- or transforming growth factor α-stimulated corneal epithelial cell motility. 
Exogenous Lm-332, however, promoted cell adhesion. The deposition of Lm-332 
isoforms by adhering HCE cells was distinct since Lm-3’32 was seen as an even plaque 
extending from the cell centre to the periphery, but Lm-332 was restricted to the oval 
plaque beneath the cell body after 2 h of adhesion. The role of Lm-332 isoforms was 
further studied by immunostaining wounded HCE cell cultures. After an overnight 
migration, the marginal HCE cells along the wound edge and some of the supramarginal 
cells showed a bright cytoplasmic immunoreactivity for the Lm ?3’ chain. Similar results 
were reported previously with migrating epidermal keratinocytes, which expressed Lm-
3’32 at the wound healing front (Lampe et al., 1998; Nguyen et al., 2000). The emergence 
of cytoplasmic Lm-?3’ also in supramarginal cells could indicate the cellular tensegrity 
forces mediating mechanical information (Ingber, 1997). A bright immunoreactivity was 
also observed for the Lm ?3 chain in the moving marginal cells. Lm ?3 chain and Tn-CL,
by contrast, were not found in in vitro wounds, but both were present diffusely in the 
unwounded HCE cell culture substratum. Based on these results, we conclude that Lm-332 
isoforms have distinct roles in the adhesion, spreading and migration of HCE cells. In line 
with earlier studies, we suggest that Lm-3’32 participates in spreading and migration of 
HCE cells during corneal wound healing. On the other hand, Lm-332 and Tn-CL were
found as restricted plaques beneath the adhering HCE cells, but not in migrating HCE 
cells. This result confirms that Lm-332 and Tn-CL initiate the early adhesion of HCE cells.
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8.5.3 Production and secretion of chains of laminin-332 and tenascin-C by early 
adhering HCE cells (IV) 
The synthesis of Lm-332, Lm-3’32, Tn-C and Tn-CL was studied by using 2-h adhered 
and S35-methionine-labeled HCE cells. In the ECM specimen, a 200 kD polypeptide, 
corresponding to the Lm ?3’ chain, was detected. In addition, a 165 kD polypeptide, 
corresponding to the Lm ?3 chain, a 140 kD polypeptide, corresponding to the Lm ?3
chain and 155 kD and 105 kD polypeptides, corresponding to Lm ?2’ and ?2 chains, were 
detected in ECM. The culture medium lacked the Lm ?3’ chain and very weak bands were 
obtained with antiserum against Lm-332. MAb against both subunits of Tn-C detected 
only a 290 kD band in the cell-free ECM preparation, corresponding to Tn-CL. Some non-
specific binding was also seen as high Mr bands. We therefore suggest that adhering HCE 
cells synthesize both Lm-332 and Lm-3’32 as well as Tn-C L. This result does not support 
earlier studies showing that keratinocytes and HCE cells secrete only Lm-3’32, which 
becomes processed after secretion (Ebihara et al., 2000; Nguyen et al., 2000). However, 
both Lm-332 isoforms can be secreted depending on the cell line (Goldfinger et al., 1998). 
Additional evidence supporting adhering HCE cells synthesizing and depositing both Lm-
332 isoforms lies in their different distribution beneath the early adhering HCE cells.
Furthermore, our results suggest that most Tn-CL and Lm-3’32 are directly delivered to 
the ECM. This result prompted us to further investigate the secretion and deposition of 
Lm-332 and Tn-CL. First, the position of the Golgi apparatus was determined in 2-h 
adhered HCE cells with immunofluorescence by using MAb GM130 specific for a Golgi 
protein, and CLSM imaging. The immunoreactivity for the Golgi apparatus was located to 
the vicinity of the deposited Lm-332 plaque. Thereafter, the cells were exposed to 
demecolcine over a  2-h adhesion. As a result of this disrupting treatment for microtubules 
and the Golgi apparatus, immunoreactivities for Lm-332 and Tn-CL plaques were not 
found beneath the adhering HCE cells. Instead, both proteins were observed diffusely 
around and beneath the HCE cells. A different pattern was seen when HCE cells adhered 
in the presence of cytochalacin-B, which disrupts the microfilaments. Now both Lm-332- 
and Tn-CL-immunoreactive plaques were found underneath the arborized cells. Since only 
demecolcine treatment affected the formation of Lm-332- and Tn-CL-immunoreactive
plaques, we suggest that these proteins are vectorially secreted and directed from the Golgi 
apparatus underneath HCE cells via microtubules.
8.5.4 Adhesion of HCE cells to laminin-332, tenascin-C and laminin-332/tenascin-C 
(IV)
We have previously shown that HCE cells adhere to endogenous Lm-332 as well as to 
purified exogenous Lm-332. However, the cells did not adhere to Tn-C if cycloheximide 
was applied to inhibit endogenous protein synthesis. Our main interest was to elucidate the 
role of these proteins in early adhesion since both are deposited beneath the adhering HCE 
cells. The adhesion characteristics of HCE cells to Lm-332/Tn-C and Lm-332 coats were 
compared by quantitative cell adhesion experiments with or without cycloheximide. These 
experiments showed that HCE cells adhered similarly to both of these substrata, and 
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cycloheximide did not alter these results. Integrins ?3 and ?1 similarly functioned in the 
adhesion of HCE cells to both Lm-332/Tn-C and Lm-332. A hemidesmosomal component, 
integrin ?4, which appears later during spreading of the HCE cell, did not function in the 
adhesion of HCE cells to these substrata. 
Hemidesmosomes are known to mediate stable adhesion of keratinocytes (Borradori and 
Sonnenberg, 1996; Nguyen et al., 2000), and matricellular proteins, such as Tn-C, 
interfere with cell adhesion and induce an intermediate state of adhesion (Murphy-Ullrich, 
2001). As corneal epithelial cells are required to migrate and cover the defective area 
rapidly, the assembly of hemidesmosomes would be unsuitable in early corneal wound 
healing. Immortalized gingival keratinocytes, on the other hand, produce and deposit Lm-
332 similarly to HCE cells (Pakkala et al., 2002), but do not deposit Tn-C during early 
adhesion (Virtanen et al., unpublished data). Based on our results and earlier studies 
showing the role of Tn-C as a modulator of cell-ECM interactions, we suggest that Tn-CL
may prevent the assembly of hemidesmosomes when deposited together with Lm-332 in 
HCE cells. Pal-Ghosh et al. (2004) also hypothesized that the retention of Tn-C in the 
anterior stroma in corneal wounds could interfere with hemidesmosome reassembly. 
However, they suggested that Tn-C stops the activation of integrins ?3ß1 and ?6ß4 by 
inhibiting RhoGTP, which converts the migrating cells to a quiescent phenotype. This 
result is not supported by our study, and we suggest that Tn-CL functions in the motility of 
HCE cells and cooperates with Lm-332 isoforms during corneal wound healing. Our 
results concerning the role of BM and ECM proteins in corneal wound healing are 
summarized in table 5.
Table 5. Production and function of basement membrane and extracellular matrix proteins in 
corneal wound healing
Production of BM and ECM 
proteins by HCE cells 
Expression of BM and 
ECM proteins in in vitro 
wounds
Suggested functions for BM 
and ECM proteins in 
corneal wound healing 
Lm-3?32 + Epithelial cell spreading 
and migration 
Lm-332 - Epithelial cell adhesion 
Tn-CL - Prevention of the assembly 
of hemidesmosomes 
Epithelial cell migration 
EDA-Fn Not studied Epithelial cell adhesion and 
migration
Assembly of FAs 
Onc-Fn Not studied Epithelial cell adhesion and 
migration?
Assembly of FAs? 
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9. CONCLUSIONS AND FUTURE PROSPECTS 
In vitro wound healing studies show that migrating HCE cells express the Lm ?3? chain
along the wound edge and in supramarginal cells. In Addition, the Lm ?3? chain is found 
underneath adhering HCE cells, extending from the cell centre to the periphery, whereas 
the Lm ?3 chain is deposited to restricted and centrally oriented plaques beneath HCE 
cells. We therefore suggest that Lm- 3?32 functions in spreading and migration of 
epithelial cells during corneal wound healing, while Lm-332 mediates the initial adhesion 
of these cells. 
Our adhesion studies reveal that HCE cells do not adhere to Tn-C, although Tn-C is 
deposited together with Lm-332 underneath the adhering HCE cells. Lm-332 is known to 
function in the formation of hemidesmosomes via integrin ?6?4. These structures mediate 
strong adhesion of basal corneal epithelial cells to the BM and disappear from the wound 
margins. Since integrin ?4 does not function in the early adhesion of HCE cells and 
appears later during the spreading, we suggest that Tn-C may prevent the formation of 
hemidesmosomes when deposited with Lm-332. Hence, Tn-C could function in the 
migration of corneal epithelial cells during wound healing. However, in in vitro wound 
healing studies we could not find Tn-C in the migrating HCE cells, although this protein is 
present in cultured confluent cells. This discrepancy requires further consideration. 
Integrin ?3?1 and Lu mediated the adhesion of HCE cells to Lm-511, which promotes 
HCE cell spreading. During this adhesion both talin and Lu showed diffuse punctuate 
immunoreaction in HCE cells. On the other hand, when fibronectin was added to the 
adhesion substratum together with Lm-511, talin was located in FAs, while Lu remained 
diffusely distributed in HCE cells. FAs are known to play a role in both cell motility 
(Zaidel-Bar et al., 2003) and strong adhesion, which prevents cell migration (Murphy-
Ullrich, 2001). We suggest that Lm-511 can favour the intermediate state of HCE cell 
adhesion by inducing cell spreading without inducing FAs. In addition, since Lm-511 does 
not prevent the formation of FAs, the cells can assemble these structures during migration.
HCE cells secreted EDA-Fn and Onc-Fn to the matrix and medium. Fibronectin serves as 
an adhesive substratum for HCE cells and induces integrins ?5, ?v, ?1 and ?6 to FAs. We 
found that integrin ?5?1 mediated the adhesion of HCE cells to the RGD sequence of 
fibronectin. Although, integrin ?v?6 did not function alone in the adhesion of HCE cells to 
fibronectin, cell adhesion was inhibited nearly completely when both MAbs against 
integrin ?5?1 and ?v?6 were applied together. The mechanism behind this phenomenon 
requires further examination. We found that Tn-C, which is secreted to the ECM, can 
modulate the adhesion of HCE cells to fibronectin. However, it did not affect FA 
formation induced by fibronectin. We conclude that also fibronectin, which is secreted to 
the provisional matrix during wound healing, cooperates with Tn-C during cell adhesion 
and migration. 
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The topical application of fibronectin ophthalmic solution has shown promising results in 
the treatment of persistent epithelial defects. Kimura et al. (2007) showed that the PHSRN 
peptide, a second cell-binding site of fibronectin, increased HCE cell motility in vitro. 
However, because fibronectin is isolated from blood and may be contaminated with 
infectious agents, it has not become a commercial product. Patients have instead been 
treated with autologous serum eye drops. Since these eye drops contain a large variety of 
growth factors, immunoglobulins and vitamins as well as fibronectin, it has proven to be a 
successful treatment for corneal epithelial wounds (Akyol-Salman, 2006; Geerling et al., 
2004). Kabata et al. (1990) suggested that also topically applied vitronectin increases 
corneal wound healing. We propose that in the future the topical application of Lm-332 
and vitronectin may have a place in the prevention of recurrent corneal erosion, as they 
mediate the adhesion of corneal epithelial cells. The combination of Lm-3?32, Tn-CL, Lm-
511 and fibronectin could be applied for the treatment of corneal epithelial wounds to 
accelerate cell migration. 
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